This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Tullio V, Cuffini AM, Carlone NA (1990) Mycoses 33:257–263
Heel RC, Brogden RN, Speight TM, Avery GS (1978) Drugs 16:177–201
Rindt W, Geibel W, Appel L (1979) Arzneim Forsch 29: 697–699
Vukovich A, Heald A, Darragh A (1977) Clin Pharmacol Ther 21: 121
Midgley I, Biggs SR, Hawkins DR, Chasseaud LF, Darragh A, Brodie RR, Walmsley LM (1981) Xenobiotica 11: 595–608
Gabriel G, Thin RNT (1983) Br J Vener Dis 59: 56–58
Bingham JS, Steele CE (1981) Br J Vener Dis 57: 204–207
Millikan LE, Galen WK, Gewirtzman GB, Horwitz SN, Landow RK, Nesbitt LT, Roth HL, Sefton J, Day RM (1988) J Am Acad Dermatol 18: 52–56
Bennet JE (1990) Antifungal agents. In: Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) The pharmacological basis of therapeutics, Pergamon Press, New York, S. 1165–1181
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf
Tammelin IE (1957) Acta Chem Scand 11: 1340–1349
Fitch HM US pat. 2.911.430, zit. nach CA (1960) 54:4386i
Guo Z, Shi D, Wang S (1984) Yiyao Gongye 5:6–8, zit. nach CA (1985) 102: 6686z
Chatten LG, Napper A, Barry PJ (1967) J Pharm Sci 56: 834–838
Warner C, DiBernardo F, Bylow A, Hussain A, Kho BT (1971) J Pharm Sci 60: 1548–1549
Hussain A, Schurman P, Peter V, Milosovich G (1968) J Pharm Sci 57: 411–418
Tammelin LE (1958) Arkiv Kemi 12: 287–298
Ferry CB (1979) Br J Pharmacol 66: 466 P
Faff J, Bak W (1981) Arch Int Pharmacodyn Ther 250: 293–301
Bito LZ, Hyslop K, Hyndman J (1967) J Pharmacol Exp Ther 157: 159–169
Mandahl A (1985) Eur J Pharmacol 114: 121–127
Ashani Y, Catravas GN, Alter III WA (1981) Biochem Pharmacol 30:2. 585–2. 592
Ashani Y, Catravas GN (1981) Biochem Pharmacol 30:2. 593–2. 601
De Roetth A, Dettrarn WD, Rosenberg P, Wilensky JG, Wong A (1965) Am J Ophthalmol 59: 586–592
Leydhecker W (1985) Die Glaukome in der Praxis. Ein Leitfaden, 4. Aufl., Springer-Verlag, Berl in Heidelberg
Christakis C, Mangouritsas N (1981) Klin Mbl Augenheilkunde 179: 197–200
Axelsson U (1968) Acta Ophth 46: 83–98
Axelsson U (1969) Acta Ophth (Suppl 102 ): 22–23
Lehmann RH, Fitch HM, Bloch LP, Jewell HA, Nicholls ME (1960) J Pharmacol Exp 128: 307–317
Fechner PU (1967) Medikamentöse Augentherapie. Bücherei des Augenarztes 67, Enke, Stuttgart
American Pharmaceutical Association (1986) Handbook of Pharmaceutical Excipients Washington, USA S. 108
Muller SA, Brunsting LA, Winkelmann RK (1959) Am Med Assoc Arch Dermat 80: 187–194
Lamar CP (1966) J Am Geriat Soc 14: 272–294
Spencer H, Vankinscott V, Lewin I, Laszlo D (1952) J Clin Invest 31:1. 023–1. 027
Perry HM, Schroeder HA (1957) Am J Med 22: 168–172
Foreman H, Trujillo TT (1954) J Lab Clin Med 43: 566–571
Popovici A, Geschickter CF, Reinovsky A, Rubin M (1950) Proc Soc Exp Biol med 74: 415–417
Foreman H, Finnegan C, Lushbaugh CC (1956) J Am Med Assoc 160:1. 042–1. 046
Clarke NE, Clarke CN, Mosher RE (1956) Am J Med Sci 232: 654–666
Holland JF, Danielson E, Sahagian-Edwards A (1953) Proc Soc Exp Biol Med 84: 359–364
Dudley HR, Ritchie AC, Schilling A, Baker WH (1955) New Engl J Med 252: 331–337
Spencer H, Greenberg J, Berger E, Perrone M, Laszlo D (1956) J Lab Clin Med 47: 29–41
Editorial (1960) Am J Cardiol 6: 233–236
Casdorph HR (1981) J Holist Med 3: 53–59
Clarke NE, Clarke CN, Mosher RE (1955) Am J Med Sci 229: 142–149
Kneller LA, Uhl HSM, Brem J (1955) New Engl J Med 252: 338–340
Peters HA, Woods S, Eichman PL, Reese HH (1957) Ann Int Med 47: 889–899
Wirebaugh SR, Geraets DR (1990) Drug Intell Clin Pharm 24: 22–25
Rathmann KL, Golightly LK (1984) Drug Intell Clin Pharm 18:1.000–1.003
Leuschner U, Baumgarte H (1984) Prog Clin Biol Res 152: 193–225
Mack E (1989) Am J Surg 158: 248–250
Seven MJ (1960) Observations on the toxicity of intravenous chelating agents. In: Seven MJ, Johnson LA (Hrsg.) Metal-binding in medicine, Lippincott, Philadelphia Montreal, S. 95–103
Wedeen RP, Batuman V, Landy E (1983) Environ Res 30: 58–62
Schardein JL, Sakowski R, Petrere J, Humphrey RR (1981) Toxicol Appl Pharmacol 61: 423–428
Kimmel CA (1977) Toxicol Appl Pharmacol 40: 299–306
Heindorff K, Aurich O, Michaelis A, Rieger R (1983) Mutat Res 115: 149–173
Reuter HD, Thiele S, Mödder B (1985) Dtsch Aerztebl 82:2. 992–2. 996
Reusser P, Osterwalder B, Speck B (1986) Schweiz Med Wochenschr 116:1. 566–1. 569
Kaul R, Kiefer G, Erhardt S, Hempel B (1980) J Pharm Sci 69: 531–534
Shugar D, Swierkowski M, Fikus M, Barszcz D (1967) 7th International Congress of Biochemistry, Tokio, 1: 59–60
Hempel B (1982) Dtsch Apoth Ztg 122:1. 670–1. 672
Schwöbel W, Weiland F, Hempel B, Kaul R (1981) IRCS Med Sci 9: 1. 121
Remin H, Ekiel I, Shugar D (1975) Eur J Biochem 53: 197–206
Teh CZ, Sacks SL (1983) Antimicrob Agents Chemother 23: 637–640
Spruance SL, Freeman DJ, Seeth NV (1985) Antimicrob Agents Chemother 28: 103–106
Sacks SL, Tyrrell LD, Lawee D, Schlech W, Gill MJ, Aoki FY, Martel AY, Singer J, and the Canadian Cooperative Study Group (1991) J Infect Dis 164: 665–672
Fachinformation Aedurid (1988), Robugen GmbH, Esslingen
Bey P, Vevert JP, Van Dorsselner V, Kolb M (1979) J Org Chem 44: 2732–2742
Cohen JL, Ko RJ, Lo ATL, Shields MD, GilmanTM (1989) J Pharm Sci 78: 114–116
Smithers J (1988) Pharm Res 5: 684–686
Van Nieuwenhove S, Schechter PJ, Declerq J, Boné G, Burke J, Sjoerdsma A (1985) Trans Roy Soc Trop Med Hyg 79: 692–698
Bacchi CJ, Nathan HC, Hutner SH, McCann PP, Sjoerdsma A (1980) Science 210: 332–334
Bacchi CJ, Nathan HC, Hutner SH, McCann PP, Sjoerdsma A (1982) Biochem Pharmacol 31:2.833–2.836
Schechter PJ, Sjoerdsma A (1986) Parasitology Today 2: 223–224
De Gee ALW, McCann PP, Mansfield JM (1983) J Parasitol 66: 818–822
Giffin BF, McCann PP, Bitonti AJ, Bacchi CJ (1986) J Protozool 33: 238–243
Zweygarth E, Roettcher D (1989) Parasitol Res 75: 178–182
Doua F, Boa FY, Schechter PJ, Miezan TW, Diai D, Sanon SR, de Raadt P, Haegele KD, Sjoerdsma A, Konian K (1987) Am J Trop Med Hyg 37: 525–533
Eozenou P, Jannin J, Ngampo S, Carme B, Tell GB, Schechter PJ (1989) Med Tropic 49: 149–154
Gilman TM, Paulson YJ, Boylen CT, Heseltine PNR, Sharma OP (1986) J Am Med Assoc 256(16):2.197–2.198
Rolston KVI, Feinstein V, Bodey GP (1989) J Acquired Immune Deficiency Syndrom 2: 426–430
Hollingdale MR, McCann P, Sjoerdsma A (1985) Exp Parasitol 60: 111–117
Sjoerdsma A, Golden JA, Schechter PJ, Barlow JLR, Santi DV (1984) Transactions of the Association of American Physicians 97: 70–79
Bartholeyns J (1983) Eur J Cancer Clin Oncol 19: 567–572
Bartholeyns J, Koch-Weser J (1981) Cancer Res 41:5.158–5.161
Bacchi CJ, Berens RL, Nathan HC, Klein RS, Elegbe IA, Rao KVB, McCann PP, Marr JJ (1987) Antimi- crob Agents Chemother 31:1. 406–1. 413
Clarkson AB jr, Bienen EJ, Bacchi CJ, McCann PP, Nathan HC, Hutner SH, Sjoerdsma A (1984) Am J Trop Med Hyg 33:1.073–1.077
Haegele KD, Alken RG, Grove J, Schechter PJ, Koch- Weser J (1981) Clin Pharmacol Ther 30: 210–217
Romijn JC, Verkoelen CF, Splinter TAW (1987) Cancer Chemother Pharmacol 19: 30–34
Di Bari D, Pastore G, Roscigno G, Schechter PJ, Sjoerdsma A (1986) Ann Int Med 105: 803–804
O’Toole BA, Huffman KW, Gibson JP (1989) Teratology 39: 103–113
Robertson JS, Price RR, Budinger, TF, Fairbanks VF, Pollycove M; Report No. 11 in MIRD Primer; The Society of Nuclear Medicine, New York (1988)
Robertson JS, Price RR, Budinger TF, Fairbanks VF, Pollycove M (1988) Report No. 11 in MIRD Primer; The Society of Nuclear Medicine, New York
Otsuki H, Brunetti A, Owens ES, Finn RD, Blasberg RG (1989) J Nucl Med 30 (10): 1676–1685
Porter J (1989) Eur J Haematol 43 (4): 271–285
Robertson JS, Price RR, Budinger TF, Fairbanks VF, Pollycove M; Report No. 11 in MIRD Primer; The Society of Nuclear Medicine, New York (1988)
Spencer RP, Gupta SM (1989) Crit Rev Clin Lab Sci 27 (4): 299–318
Robertson JS, Price RR, Budinger TF, Fairbanks VF, Pollycove M; Report No. 11 in MIRD Primer; The Society of Nuclear Medicine, New York (1988)
Merck Index 10 (1983)
Merck Feinchemikalienkatalog 1990/1991
Weaver et al. (1961) Am J med Sci, S. 241, 296
Gilman AG, Goodman LS, Gilman A (1980) The pharmacological basis of therapeutics, McMillan Publ Comp Inc, New York
Rao N (1981) Brit Med Bull 37: 25–32
Hallberg L (1982) Human Nutr Clin Nutr 36C: 259–278
Huebers H, Rummel W (1984) Protein mediated epithelial iron transfer. In: Czaky TC (Hrsg.) Pharmacology of intestinal permeation, Handbuch der experimentellen Pharmakologie, Springer-Verlag, Heidelberg Berlin New York
Forth W, Rummel W (1973) Physiol Rev 53: 724–792
Jacobs A, Worwood M (1973) Iron in biochemistry and medicine, Academic Press, London New York
Forth W, Henschler D, Rummel W (1987) Pharmakologie und Toxikologie, Wissenschaftsverlag, Mannheim Wien Zürich
Reznikoff P, Goebel WF (1937) J Pharmacol Exp Ther 59:182–192, zit. nach CA 31: 2750
Zeiss O (1971) DOS (1971) 2021149, zit. nach CA 76: 59977w
Stone GB (1950) J Am Pharm Assoc, Scient Edn 39: 16
Johnson CA, Thomas JA (1954) J Pharm Pharmacol 6: 1037
Cheng G, Zhang Z, Ruan P (1988) Zhongguo Yaoke Daxue Xuebao 19:316–317, zit. nach CA 110:160487g
Herzfeldt CD, Erben A (1984) Pharmazie 39: 783–784
Singh R, Chandrakar LP, Mishra RK (1986) Bull Chem Soc Jpn 59: 1571–1573
Sullivan DJ (1977) J Assoc Off Anal Chem 60: 1350–1354
Jarzebinski J, Lugowska E (1989) Acta Pol Pharm 46:160–164, zit. nach CA 112: 25799m
Ali SL, Litterst FJ, Wagner FM (1980) Fresenius’ Z Anal Chem 302: 52–55
Gilman AG, Goodman LS, Gilman A (1980) The pharmacological basis of therapeutics, McMillan Publ Comp Inc, New York
Hallberg L (1982) Human Nutr Clin Nutr 36C: 259–278
Huebers H, Rummel W (1984) Protein mediated epithelial iron transfer. In: Czaky TZ (Hrsg.) Pharmacology of intestinal permeation, Handbuch der experimentellen Pharmakologie, Springer-Verlag, Heidelberg New York
Kaltwasser JP, Werner E (1980) Serum ferritin, Springer-Verlag, Heidelberg New York Tokyo
Rao N (1981) Brit Med Bull 37: 25–32
Jacobs A, Worwood M (1973) Iron in biochemistry and medicine, Academic Press, London New York
Buser HJ, Schwarzenbach D, Petter W, Ludi A (1977) Inorg Chem 16: 2704–2710
Bonnette AK Jr, Gandy SE (1981) J Chem Educ 58: 355–357
Ludi A sowie Antwort von Bonnette AK und Gandy SE (1983) J Chem Educ 60: 528
Ferch H, Kreher A, Pigmente, anorg.: Buntpigmente. In: Ull Bd. 18, S. 623ff
Nielsen P, Dresow B, Fischer R, Heinrich HC (1990) Arch Toxicol 64: 420–422
Nielsen P, Dresow B, Fischer R, Gabbe EE, Heinrich HC, Pfau AA (1988) Arzneim Forsch 38:1. 469–1. 471
Nielsen P, Dresow B, Fischer R, Heinrich HC (1990) Z Naturforsch (C) 45: 681–690
Villanueva E, Hernandez-Cueto C, Lachica E, Rodrigo MD, Ramos V (1990) Drug Saf 5: 384–389
Farina R, Brandao-Mello CE, Oliveira AR (1991) Health Phys 60: 63–66
Brandao-Mello CE, Oliveira AR, Valverde NJ, Farina R, Cordeiro JM (1991) Health Phys 60: 31–39
Lipsztein JL, Bertelli L, Oliveira CAN, Dantas BM (1991) Health Phys 60: 57–61
Gilman AG, Goodman LS, Gilman A (1980) The pharmacological basis of therapeutics, McMillan Publ Comp Inc, New York
Estler CJ (1983) Lehrbuch der allgemeinen und systematischen Pharmakologie und Toxikologie, Schattauer Verlag, Stuttgart New York
Forth W, Henschler D, Rummel W (1987) Pharmakologie und Toxikologie, Wissenschaftsverlag, Mannheim Wien Zürich
Hallberg L (1982) Human Nutr Clin Nutr 36C: 259–278
Forth W, Rummel W (1973) Physiol Rev 53: 724–792
Jacobs A, Worwood M (1973) Iron in biochemistry and medicine, Academic Press, London New York
Rao N (1981) Brit Med Bull 37: 25–32
Carlsson S (1952) Swed 136.606, zit. nach CA (1954) 48: 729a
Kuhnert-Brandstätter M, Bösch L, Eckstein G (1978) Sci Pharm 46: 180–188
Clarke EGC (1969) Isolation and Identification of Drugs, Bd. I, The Pharmaceutical Press, London, S. 1037
Moffat AC (Hrsg) (1986) Clarke’s isolation and identification of drugs in pharmaceuticals, body fluids, and postmortem material, 2. Aufl., The Pharmaceutical Press, London, S. 581
Ojanperä I, Vuori E (1987) J Liquid Chromatogr 10: 3595–3604
Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr 323: 191–225
Ardrey RE, Moffat AC (1981) J Chromatogr 220: 195–252
Eriksson O, Nyberg L (1967) Automat Anal Chem, Technicon Symp 3rd, 2: 269–273
Eksborg S, Persson BA, Vessman J, Enell B (1971) J Pharm Sci 60: 475–477
Schill G (1965) Acta Pharm Suecica 2: 13–46
Vessman J (1978) Method Surv Biochem 7: 119–127
Gordon SM, Freeston LK, Collins AJ, Bain R (1985) J Chromatogr 322: 246–247
Nilvebrant L, Anderson KE, Mattiasson A (1985) J Urology 134: 418–423
Anderson KE (1988) Drugs 35: 477–494
Boman J, von Garrelts B (1973) Scand J Urol Nephrol 7: 153–157
Cardozo LD, Stanton SL (1979) J Urol 122: 58–59
Low JA (1977) Am J Obstet Gynecol 128: 32–39
Massey JA, Abrams P (1986) J Urol 58: 125–128
Perera GLS, Ritch AES, Hall MRP (1982) Br J Urol 54: 250–260
Sundwall J, Vessman J, Strindberg B (1973) Eu J Clin Pharmacol 6: 191–195
Mar 29, S. 531–532
Rollo IM (1965) Drugs used in the chemotherapy of amoebiasis. In: Goodman and Gilman’s The pharmacological basis of therapeutics, 3. Aufl., MacMillan, New York, S. 1. 121–1. 124
Steck EA (1971) Walter Reed Army Institute of Research, Washington, 1:3. 126–3. 131
Lippincott JB (Hrsg.) (1989) Drug, facts and comparisons, Facts and Comparisons, St. Louis, USA, S. 1. 606–1. 607
Mohr W, Schumacher HH, Weyer F (Hrsg.) (1975) Nauck EG, Lehrbuch der Tropenkrankheiten, 4. Aufl., Thieme, Stuttgart, S. 117–118
Webster LT jr (1985) Drugs used in the chemotherapy of protozoal infections Amebiasis, Giardiasis, and Trichomoniasis. In: Goodman and Gilman’s The pharmacological basis of therapeutics, 7. Aufl., MacMillan, New York Toronto London, S. 1. 049–1. 057
Datta D V, Singh S A, Chhuttani PN (1974) Am J Trop Med Hyg 23: 586–589
Entner N (1979) J Protozool 26: 324–328
Orozco E, de la Cruz Hernandez F, Rodriguez MA (1985) Mol Biochem Parasitol 15: 49–59
Westwood JT, Wagenaar EB (1983) J Cell Sci 59: 257–268
Cohen HA, Livshin R (1987) J Am Acad Dermatol 17: 595–599
Cohen HA, Wahaba A (1979) Acta Derm Venerol 59: 549–552
Zierdt CH, Swan JC, Hosseini J (1983) J Protozool 30: 232–234
Benjapong W, Naeypatimanond S, Benjapong K, Tumaruksa C, Ruttarasarn S, Jaroonvesama H (1984) Southeast Asia J Trop Med Public Health 15: 354–359
Jesiotr M (1973) Scand J Respir Dis 54: 326–332
Chunge CN (1985) East Afr Med J 62: 279–282
Manson-Bahr PEC, Apted FIC (1982) Manson’s Tropical Diseases, 18.Aufl., Baillière Tindall, London, S. 121–145
Rees PH (1982) Drugs. In: Manson-Bahr PEC, Apted FIC (Hrsg.) Manson’s Tropical Diseases, 18. Aufl., Baillière Tindall, London, S. 614–615
Synek P (1974) Rev Czech Med 20: 29–31
Cawderry MHH (1972) Irish Vet J 26: 99–100
Napolitano RL, Dolensek EP, Behler JL (1979) Reptilian amebiasis. In: Oleny PJS (Hrsg.) International Zoo Yearbook 19: 126–131
Sepúlveda B, Martinez-Palomo A (1984) Amebiasis. In: Warren KS, Mahmoud AAF (Hrsg.) Tropical and geographical medicine, McGraw Hill Book, New York, S. 305–318
Merchant HC, Shikaripurkar NK (1964) Ind J Med Sci 18: 200–209
Knight R (1984) Amebiasis. In: Woodruff AW, Wright SG (Hrsg.) Medicine in the tropics, Churchill Livingston, Edinburgh, S. 110–111
Miletich DJ, Ivankovic AD, Albrecht RF, Toyooka ET (1973) J Pharm Pharmacol 26: 101–104
Moffat AC (Hrsg.) Clark’s Isolation and Identification of Drugs, 2. Aufl. (1986), The Pharmaceutical Press, London, S. 582
Ebel S (1977) Handbuch der Arzneimittelanalytik, Verlag Chemie, Weinheim New York, S. 319
Devaux G, Mesnard P, Cren J (1963) Prod. Probl. Pharm. 18:221–228; zit. nach CA 59: 4977q
Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin
Xuan J (1990) Zhongguo Yiyao Gongye Zazhi: 21(9):409–410, zit. Nach CA 114(12): 109064x
Kato T (1985) Anal Chim Acta 175: 339–344
Patchett AA, Harris EE, Wyvratt MJ, Tristram EW (Merck and Co., Inc.) Eur Pat Appl 12, 401
Harris EE, Patchett AA, Tristam EW, Wyvratt MJ (Merck and Co., Inc.) US 4, 374, 829
Kato T (1985) Anal Chim Acta 175: 339–345
Todd PA. Heel RC (1986) Drugs 31: 198–226
Gomez HJ, Cirillo VJ, Irvin JD (1985) Drugs 30 (Suppl I): 13–24
Ferguson RK, Irvin JD, Swanson BN, Vlasss PH, Berquist PA, Till AE, Feinberg JA (1983) Clin Pharmacol Ther 33: 254–278
Biollaz J, Schelling JL, Jarot des Combes B, Brunner DB, Desponds G, Brunner HR, Ulm EH, Hichens M, Gomez HJ (1982) Br J Clin Pharmacol 14: 363–368
Redman CWG, Kelly JG, Cooper WD (1990) Eur J Clin Pharmacol 38: 99–107
Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Hichens M, Irvin J, Huber P (1982) Clin Pharmacol Ther 32: 48–53
Fruncillo RJ, Rocci ML, Vlasses PH, Mojaverian P, Shepley K, Clementi RA, Oren A, Smith RD, Till AE, Rilley LJ, Krishna G, Narins RG, Ferguson RK (1987) Kidney Int 31 (Suppl 20): 177–182
Mann J, Ritz E (1988) Therapiewoche 38:1. 883–1. 890
Consensus Study Group (1987) N Engl J Med 316:1. 429–1. 435
Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman B, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes V, Carson P, Cintron G, Shabetai R, Haakenson C (1991) N Engl J Med 325: 303–310
Solvd Investigators (1991) N Engl J Med 325: 293–302
Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M (1992) Br Med J 304: 339–343
Todd PA, Goa KL (1989) Drugs 37: 141–161
McAreavey D, Robertson JIS (1990) Drugs 40: 326–345
Bristol-Myers Co. (1983) NL 8204775; ref. (1983) zit. nach CA 99:122325z
Dykstra SJ, Minielli JL, Mead Johnson and Co. (1976) U.S. 3,931,195; ref. (1976) zit. nach CA 86:139872e
Dykstra SJ, Minielli JL, Lawson JE, Ferguson HC, Dungan KW (1973) J Med Chem 16:1.015–1.020
Vaughan Williams EM (1984) J Clin Pharmacol 24: 129–135
Brogden RN, Todd PA (1987) Drugs 34: 519–538
Sami M, Mason JW, Ott G, Harrison DC (1979) Am J Cardiol 43:1.149–1.155
Samuelson RG, Harrison DC (1981) Am J Cardiol 48: 871–876
Wang T, Roden DM, Wolfenden HT, Woosley RL, Wood AJJ (1984) J Pharmacol Exp Ther 228: 605–612
Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin
Schenker E, Salzmann R (1979) Arzneim Forsch 29:1.835–1.843
Schenker E, Sandoz AG (1975) CH 565797; ref. (1975) zit. nach CA 83: P 206311z
Reece PA, Cozamanis I, Zacest R (1981) J Chromatogr 225: 151–160
Gfeller JC, Haas R, Troendl JM, Erni F (1984) J Chromatogr 294: 247–259
Elliott HL, Meredith PA, Sloan L, Reid JL (1984) Eur J Clin Pharmacol 27: 159–163
Kráčmar J, Kráčmarová J, Moravcová B, Helingerová H (1989) Pharmazie 44: 199–203
Terrell RC, Speers L, Szur AJ, Treadwell J, Ucciardi TR (1971) J Med Chem 14: 517–519
Speers L, Szur AJ, Terrell RC (1972) J Med Chem 15: 606–608
Koehler KA, Stone EE, Shelton RA, Jarnagin F, Koehler LS, Fossel ET (1978) J Magn Res 30: 75–84
Brückner JB (1976) Inhalationsanästhesie mit Ethrane, Anaesthesiologie und Wiederbelebung, Bd. 99, Springer Verlag, Berlin Heidelberg New York
Urban BW (1992) Anästhesiol Intensivmed Notfallmed Schmerzther 27: 68–75
Quasha AL, Eger EI II, Tinker JH (1980) Anesthesiology 53: 315–334
Eger EI II (1980) The uptake and distribution of inhalational anaesthetic agents. In: Nunn JF, Utting J (Hrsg.) General Anaesthesia, 4. Aufl., Butterworth, London
Chase RE, Holaday DA, Fiserova-Bergerova V (1971) Anesthesiology 35: 262–267
Cousins MJ, Greenstein LR, Hitt BA, Mazze RI (1976) Anesthesiology 44: 44–53
Lowe HJ, Ernst EA (1981) The quantitative practice of anesthesia. Use of closed circuit, Williams & Wilkins, Baltimore London
Eger EI II, Smuckler EA, Ferrel LD (1986) Anesth Analg 65: 21–30
Imazalil (1977) Joint Meeting of the FAO Working Party of Experts and the WHO Expert Committee of Pesticide residues ( JMPR ), S. 283–303
Thienpont D, van Cutsem J, van Cauteren H, Marsboom R (1981) Arzneim Forsch 31 /2: 309–315
Mayer H (1983) Berl Muench Tieraerztl Wochenschr 96: 458–459
Laville E, Harding PR, Dagan Y, Rahat M, Kraght AJ (1977) Proc Int Soc Citriculture 1: 269–273
Löscher W, Ungemach FR, Kroker R (1991) Grundlagen der Pharmakotherapie bei Haus- und Nutztieren, Parey, Berl in Hamburg
Henwood JM, Monk JP (1988) Drugs 36: 32–66
Beckmann J, Elsässer W, Gundert-Remy U, Hertrampf R (1987) Eur J Clin Pharmacol 33: 227–230
Wijnands WJA, Vree TB, vanHerwaarden CLA (1985) Br J Clin Pharmacol 20: 583–588
Various authors (1984) J Antimicrob Chemother 14 (Suppl C): 1–94
Simpson KJ, Brodie MJ (1985) Lancet ii:161
Christ W, Lehnert T (1990) Toxicity of the quinolones. In: Siporin C, Heifetz CL, Domagala JM (Hrsg.) The new generation of quinolones, Marcel Dekker Inc, New York, S. 165–187
Harder S, Staib AH, Beer C, Papenburg A, Stille W, Shah PM (1988) Eur J Clin Pharmacol 35: 651–656
Staib AH, Harder S, Mieke S, Beer C, Stille W, Shah PM (1987) Meth Find Exp Clin Pharmacol 9:193– 198
Staib AH, Stille W, Dietlein G, Shah PM, Harder S, Mieke S, Beer C (1987) Drugs 34 (Suppl 1): 170–174
Wijnands WJA, Vree TB, Baars AM, van Herwaarden CLA (1987) Drugs 34 (Suppl 1): 159–169
Grasela TH jr, Schentag JJ, Sedman AJ, Wilton JH, Thomas DJ, Schultz RW, Lebsack ME, Kinkel AW (1989) Antimicrob Agents Chemother 33: 615–617
Sörgel F, Jaehde U, Naber K, Stephan U (1989) Clin Pharmacokin 16 (Suppl 1l): 5–24
Toothaker RD (1989) Clin Pharmacokin 16 (Suppl 1): 52–58
Wood MJ (1989) Clin Pharmacokin 16 (Suppl 1): 38–45
Edwards DJ, Bowles SK, Svensson CK, Rybak MJ (1988) Clin Pharmacokin 15: 194–204
Paton JH, Reeves DS (1991) Drug Safety 6: 8–27
Neumann M (1988) Clin Pharmacokin 14: 96–121
Misiak PM, Eldon MA, Toothaker RD, Sedman AJ (1993) J Clin Pharmacol 33: 53–56
Schnettler RA, Dage RC, Grisar JM (1982) J Med Chem 25:1. 477–1. 481
Hausmyer CL, Lewis RL (1991) Pharm Res 8: 903–907
Hood WB (1989) Am J Cardiol 63: 46A–53A
Von der Leyen H, Meyer W (1991) Arzneim Ther 9: 42–55
Wada Y, Taira N (1986) Heart Vessels 2: 29–35
Erbel R, Treese N (Hrsg.) (1989) J Cardiovasc Pharmacol 14 (Suppl 1): 1–83
Weber KT (Hrsg.) (1987) Am J Cardiol 60: 1c–90c
Endoh M, Yamagisawa T, Taira N, Blinks JR (1986) Circulation 73:(3Pt2), III 117–133
Pop I, Treese N, Cremer GM, Haegele KD, Meyer J (1986) Int J Cardiol 12: 223–232
Simonton CA, Daly PA, Kereiakes D, Modin G, Chatterjee K (1987) Chest 92: 118–123
Treese N, Erbel R, Rhein S, Diefenbach C, Alken RG, Mohr-Kahaly S, Meyer J (1987) Dtsch Med Wochenschr 112:1. 163–1. 169
Khalife K, Zannad F, Brunotte F, Belhadj K, Juilliere Y, Iannascoli F, Gilgenkrantz JM (1987) Am J Cardiol 60: 75C–79C
Maskin CS, Weber KT, Janicki JS (1987) Am J Cardiol 60: 63C–67C
Kramer W, Waas W, Tillmans H (1991) Arzneim Ther 9: 102–110
Okerholm RA, Chan KY, Lang JF, Thompson GA, Ruberg SJ (1987) Am J Cardiol 60: 21C–26C
Fricke U, Klaus W (1991) Neue Arzneimittel 1990/91, Enoximon, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 192–202
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identifikation of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 584
Elks J, Ganellin CR (1990) Dictionary of Drugs, Chapman and Hall, London, S. 607–608
Beaton JM, Springs FS (1955) J Chem Soc 3126–3129
Sanduja R, Martin GE, Weinheimer AJ, Alam M, Hossain MB, van der Helm D (1984) J Heterocyclic Chem 21: 845–848
Brieskorn CH, Mahran GH (1960) Arch Pharm (Weinheim) 293: 1075–1078
Habib AAM, El-Sebakhy NA, Kadry HA (1979) J Pharm Sci 68: 1221–1223
DOC
Ohtsuka J (1973) Bull Chem Soc Japan 46: 506–509
Grgurinovich N (1986) J Chromatogr 380: 342–346
Persson CGA, Andersson KE, Kjellin G (1986) Life Sci 38:1. 057–1. 072
Erjefält I, Persson CGA (1986) Acta Physiol Scand 128: 653–654
Chapman KR, Bryant D, Marlin GE, Mitchell C, Ruffin R, Inouye T, Pedersen B, Koskinen S, Sende Osen S, Ringdal N, Willey RF, Formgren H, Persson CGA, Kallen A, Ljungholm K (1989) Am Rev Resp Dis 139: 688–693
Borga O, Andersson KE, Edholm LE, Fagerstroem PO, Lunell E, Persson CGA (1983) Clin Pharmacol Ther 34: 799–804
Larusen LC, Johannesson N, Weeke B (1985) Eur J Clin Pharmacol 29: 115–117
Tegner K, Borga O, Svenson I (1983) Eur J Clin Pharmacol 25: 703–708
Borga O, Larsson R, Lunell E (1986) Eur J Clin Pharmacol 30: 221–223
Kraan J, Jonkman JHG, Keoter GH, Gips CH, De Jong PE, Van der Mack ThW, Ekman I, De Zeeuw RA (1988) Eur J Clin Pharmacol 35: 357–362
Lunell E, Borga O (1987) Eur J Clin Pharmacol 32: 67–70
Conradson TB (1986) Acta Pharmacol Toxicol 58: 204–208
Vik-Mo H, Gulsvik A, Folling M (1988) Chest 94: 354–359
Tiplady B, Fagan D, Lamont M, Brockway M, Scott BB (1990) Br J Clin Pharmacol 30: 55–61
Arnold JD, Courtenay-Evans RJ, Whitfield R, O’Reilly JF, Petrie GR, Higgins AJ, Swift CA (1990) Res Med 84: 211–215
Drug Fut 7 (1982) 812–814
Kenley RA, Lee KM; Mahoney TR (1986) J Liq Chromatogr 9:3. 577–3. 595
Kenley RA, Partridge IW, Fleitmann JS (1986) J Liq Chromatogr 9:2. 457–2. 470
Kenley RA, Chaudhrys S, Viser GC (1986) J Pharm Sci 75: 999–1. 002
Soll AH, Chen M, Amirian D, Toomey M, Alvarez R (1986) Am J Med 81 (Suppl 2A): 5–11
Buchanan N, Laferla G, Hearns J, Buchanan KD, Crean GP, McColl KEL (1986) Am J Med 81 (Suppl 2A): 40–43
Waterbury LD, Mahoney JM, Peak TM, Cohn RG, Garay GL (1986) Am J Med 81 (Suppl 2A): 30–33
Heylings JR, Feldman M (1986) Prostaglandins 32: 907–917
Crobach LF, Jansen JB, Lambers CB (1986) Gut 27: A1282
Stanski DR, Burch PG, Tomlinson R, Sevelius H (1982) Clin Pharmacol Ther 31: 273
Thomson AB (1986) Am J Med 81 (Suppl 2A): 59–63
Navert H (1986) Am J Med 81 (Suppl 2A): 75–79
Rohner HG, Beckenbach HP, Daake H, Dammann HG, Hüttemann R, Kalek S, Kühn V, Müller P, Simon B (1986) Z Gastroenterol 24: 257–261
Winters L, Willox R, Ligny G, Barbier P, Deltenre M (1986) Am J Med 81 (Suppl 2A): 69–74
Neu HC, Labthavikul P (1982) Antimicrob Agents Chemother 22: 23–27
Ball AP (1986) Eur J Microbiol 5: 214–219
Crumplin GC, Kenwright M, Hirst T (1984) J Antimicrob Chemother 13: 9–23
Cozzarelli NR (1980) Science 207: 953–960
Drlica K (1984) Microbiol Rev 48: 273–289
Dickgiesser N (1984) Immun Infekt 12: 298–302
Wolfson JS, Hooper DC (1985) Antimicrob Agents Chemother 28: 581–586
Adam D, Christ W (1987) Antibiotika und Chemotherapeutika. In: Forth W, Henschler D, Rummel W (Hrsg.) Allg. und spez. Pharmakologie und Toxikologie, 5. Aufl., Bibliographisches Institut, Mannheim Wien Zürich, S. 655–662
Förster D (1987) Vet Med Nachr 2: 100–103
Scheer M (1987) Vet Med Nachr 2: 90–99
Smith JT (1986) Mode of action of the 4-quinolone antibacterial agents in: Ciprofloxacin, Product Monograph, Aids Press, New Zealand, S. 19–31
Scheer M (1986) Dt Geflügelwirtschaft Schweineprod 38: 591–593
Scheer M, Bauditz R (1986) Baytril: Antibakterielle Aktivität sowie Serum- und Gewebespiegel beim Kalb, Proceedings: 14. Weltkongreß Rinderkrankheiten, Dublin, S. 64–65
Scheer M, Bauditz R, Linke H (1986) Baytril: Antibakterielle Wirksamkeit sowie Serum- und Gewebespiegel bei Schweinen, Proceedings: 9th Congress IPVS, Barcelona, S. 46–49
Sindern P (1985) Vet Med Diss, TiHo Hannover
Awed-Masalmeh M, Willinger H (1987) Wien Tieraerztl Monatsschr 74: 105–108
Glawischnig E, Frank H, Weber E (1989) Wien Tieraerztl Monatsschr 76: 91–96
Redmann T, Glünder G, Schildger B, Göbel T, Kaleta EF (1989) Dtsch Tieraerztl Wochenschr 96: 137–138
Hinz KH, Will B (1988) Berl Muench Tieraerztl Wochenschr 101: 408–412
Schöning-Karakuyu G (1986) Vet Med Diss, FU Berlin
Kroker R (1991) In: Löscher W, Ungemach FR, Kroker R (Hrsg.) Grundlagen der Pharmakotherapie bei Haus- und Nutztieren, Parey, Berl in Hamburg
Franklin A, Törnquist M (1986) Feldversuche mit einer neuen antibakteriellen Substanz gegen Atemwegserkrankungen bei Kälbern, Proceedings: 14. Weltkongreß Rinderkrankheiten, Dublin, S. 83–87
Rottmann S (1986) Vet Med Diss, TiHo Hannover
Beer KP (1986) Vet Med Diss, TiHo Hannover
Randall C, Walker MD, Wright AJ (1987) Mayo Clin Proc 62:1.007–1.012
Kammermeier J (1986) Vet Med Diss, TiHo Hannover
Scheer M (1987) Vet Med Nachr 2: 104–118
Franklin A, Aström G (1986) Concentration of a new quinolone drug in bovine plasma and milk, Symp on Mastitis Control and Hygienic production of milk, Espoo, Finnland
Christ W, Schmidt V (1984) Fortschr Antimikrob Antineoplast Chemother 3–5: 795–804
Bauditz R (1987) Vet Med Nachr 2: 137–140
Sanders CC, Sanders WE, Goering EV, Werner V (1984) Antimicrob Agents Chemother 26: 797–801
King A, Shannon K, Phillips I (1985) J Antimicrob Chemother 15: 551–558
Chen KK, Schmidt CF (1930) Medicine 9: 1–117
Hoffman BB, Lefkowitz RJ (1990) Catecholamines and sympathicomimetic drugs. In: Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) The Pharmacological Basis of Therapeutics, 8. Aufl., Pergamon Press, New York, S. 187–243
Brooks DJ, Redmond S, Mathias CJ, Bannister R, Symon L (1989) J Neurol Neurosurg Psychiatry 52: 962–966
Mar 29, S. 1.462–1.463
Pasquali R, Cesari MP, Melchionda N, Stefanini C, Raitano A, Labo G (1987) Int J Obes 11: 163–168
Zarrindast MR, Hosseini NT, Farnovdi F (1987) Gen Pharmacol 18: 559–561
Wilkinson GR, Beckett AH (1968) J Pharmacol Exp Ther 162: 139–147
Sever PS, Dring LG, Williams RT (1975) Eur J Clin Pharmacol 9: 193–198
Baily A, Lau B, Watson ID, Stewart MJ (1988) Clin Chem 34: 427–428
Huff RW (1989) Med Clin North Am 73: 653 - 660
Rubin PC (1986) Br Med J 293:1. 415–1. 417
Davies B, Bannister T, Sever P (1978) Lancet I: 172–175
Wollersheim H, Netten PM, Lutterman JA, Lenders JW (1989) Angiology 40:1. 030–1. 034
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Mitteilungen der Firma Boehringer Ingelheim
BAz Nr. 148 vom 10.08. 1991. Jg 43: 5. 357
Brogden RN, Avery GS (1972) Drugs 3: 314–330
Dimmling T (1975) Untersuchungen über das Wirkungsspektrum, die Serumkonzentrationen und Ex- kretion von Spectacillin. Med Klin 70: 569–574
Zeelen FJ (1990) Medicinal chemistry of steroids, Elsevier, Amsterdam Oxford New York Tokyo, S. 216–217
Genazzani A, Massafra C, D’Ambrogio G, Kicovic PM (1979) Efficacy of “epimestrol” on the central control of human ovulation. In: Zichella L, Pancheri P (Hrsg.) Psychoneuroendocrinology in Reproduction, Elsevier North-Holland Biomedical Press, Amsterdam S. 321–326
Fachinformation Stimovul der Fa. Organon (1987)
Bohnet HG, Hanker JP, Hilland W, Schneider HPG (1980) Fertil Steril 34: 346–350
Hammerstein J, Schmidt B (1981) Role of epimestrol in induction of ovulation with special reference to 126 pregnancies. In: Insler V, Bettendorf G (Hrsg.) Advanced Diagnosis and Treatment of Infertility, Elsevier, North-Holland Amsterdam, S. 131–136
Kicovic PM, Massafra C, D’Ambrogio G, Genazzani AR (1987) Induction of ovulation in chronic anovulatory syndrome through a weak estrogen supplementation. International Congress Ser No. 515, Endocrinological Cancer, Ovarian Function and Disease, Excerpta Medica, Amsterdam, S. 236–244
Cortes-Prieto J, Martinez MR, Presenti B, Soler-Villalobos A, Clavijo MG (1981) Reproduction 5: 49–50
Clark JH, Markaverich BM (1983) Pharmacol Ther 21: 429–453
Ehrhart G, Ruschig H (1972) Arzneimittel, Bd. II, Verlag Chemie, Weinheim/ Bergstraße, S. 151
Hawkins CJ, Klease GT (1973) Austr J Chem 26: 2553
Graf E, Preuß FR (Hrsg.) (1966) Gadamers Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte, Bd. II, Göttingen-Vandenhoeck & Ruprecht, S. 415
Lyle GG (1960) J Org Chem 25: 1779
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Thies H, Özbilici Z (1962) Arch Pharm 295: 194
Reisch J, Alfes H, Möllmann H (1968) Fresenius’ Z Anal Chem 238: 29
Lambert F, Ellenberger M, Merlin L, Cohen Y (1975) OMR 7: 266
Lai A, Monduzzi M, Saba G (1981) J Chem Soc Farad Trans 2: 227
Thoma K, Struve M (1986) Pharm Acta Helv 61:2 und 34
Ermer E (1982) Pharm Ztg 127: 2219
Trendelenburg U, Weiner N (Hrsg.) (1988) Catecholamines I. Handbook Exp Pharmacol 90, Springer Verlag, Berl in Heidelberg
Kopin IJ (1986) Pharmacol Rev 37: 333–358
Bulbring E, Tomita F (1987) Pharmacol Rev 39: 50–96
Graham RM (1990) Cleveland Clin J Med 57: 481–491
Homcy CJ, Graham RM (1985) Circ Res 56: 635–650
Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM (1990) Circulation 82 (Suppl 1): I12–I25
Callaham ML (1990) West J Med 152: 697–703
Brown CG, Werman HA (1990) Resuscitation 19: 1–16
Lollgen H, Drexler H (1990) Crit Care Med 18: S56–S60
Fellner MJ (1976) Int J Dermatol 15: 497–504
Corren J, Schocket AL (1990) Postgrad Med 87: 167–168
Podrid PJ (1990) Am J Cardiol 65: 33E–44E
Rona G (1985) J Mol Cell Cardiol 17: 291–306
Arcamone F, Penco S, Vigevani A, Redaelli S, Franchi G (1975) J Med Chem 18: 703–707
Thomas AH, Quinlan GJ, Gutteridge JMC (1984) J Chromatogr 299: 489–494
Casazza AM, Di Marco A (1978) Antitumor activity, toxicity and pharmacological properties of 4’-epi-do-xo-rubicin. In: Siegenthaler W, Lüthy R (Hrsg.) Current Chemotherapy, Bd.2, Washington, Am Soc Microbiol, S. 1.257–1. 260
Di Marco A (1984) Epirubicin: mechanism of action at the cellular level. In: Bonadonna G (Hrsg.) Advances in anthracycline chemotherapy: epirubicin. Masson Italia Editori, Milano, S. 41–50
Di Marco A, Casazza AM, Dasdia T, Necco A, Pratesi G, Rivolta P, Velcich A, Zaccara A, Zunino F (1977) Chem Biol Interact 19: 291–302
Arcamone F, Cassinelli G, Penco S, Vicario GP, Igava-ni A (1984) Chemistry of epirubicin. In: Bonadonna G (Hrsg.) Advances in anthracycline chemotherapy: Epirubicin. Masson Italia Editori, Milano, S. 3–28
Tanaka M, Yoshida S, Kimura K (1983) Gann 74: 829–836
Hill BT, Whelan DH (1982) Tumori 68: 29–37
Isetta AM, Trizio D (1981) Effect of new anthracycline antibiotics on humoral and cell mediated immunresponse in vivo. Twelfth Intern Congr Chemother, Florence, Abstr. PP115 N351
Villani F, Favalli L, Piccinini F (1980) Tumori 66: 689–697
Young CW, Weenen H (1984) Pharmacology of epirubicin. In: Bonadonna G (Hrsg.) Advances in anthracycline chemotherapy: epirubicin. Masson Italia Editori, Milano, S. 51–61
Ganzina F (1983) Cancer Treat Rev 10: 1–22
Weenen H, Lenhelma JP, Penders PGM, McVie JG, Ten Bokkel Huinink WW, De Planque MM, Pinedo HM (1983) Investig New Drugs 1: 59–64
Camaggi CM, Strochi E, Tamassia V, Martoni D, Martini A, Pannuti F (1982) Cancer Treat Rep 66:1. 819–1. 824
Broggini M, Colombo T, Martini A, Donelli MG (1980) Cancer Treat Rep 64: 897–904
Jones WG, Mattson W (1984) Cancer Treat Rep 68: 675–677
Scheulen ME (1989) Klinische Pharmakologie der wöchentlichen fraktionierten Behandlung mit Epirubicin. Eine Übersicht. In: Scheulen ME, Niederle N (Hrsg.) Wöchentlich fraktioniertes Epirubicin, klinische Pharmakologie und Indikation. Aktuelle Onkologie 52, Zuckschwerdt Verlag, München Wien San Francisco, S. 3–25
Bonfante V, Villani F, Bonadonna G (1982) Tumori 68: 105–111
Young CW, Wittes R, Deesen P, Jones B, Casper E, Warnell R (1982) Clinical studies of new anthracycline analogs. In: Muggia FM, Young CW, Carter SU (Hrsg.) Anthracycline antibiotics in cancer therapy. Martinus Nijhoff Publishers, The Hague Boston London, S. 504–514
Bucciarelli E (1981) J Natl Cancer Inst 66: 81–84
Marzin D, Jasmin C, Maral R, Mathe G (1983) Eur J Cancer Clin Oncol 19: 641–647
Mondino A (1982) Teratogenesis study in the Charles River CD (SD) BR rat using IMI28 iv. RBM report no 413 (Basisinformation der Herstellerfirma)
Mauvernay RY (1966) Neth Pat 6.602.581, zit. nach CA (1967) 66: 55520n
Vejdelek Z, Protiva M (1983) Collect Czech Chem Commun 48: 2977–2988
Toffel-Nadolny P, Gielsdorf W (1981) Arzneim Forsch 31 (I): 719–722
Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308: 413–427
Bürgi H (1971) Gaz Med France 29:4. 825–4. 830
Vacher J, Lakatos C, Ripat P, Duchene-Maurllaz P (1967) Arch Int Pharmacodyn Ther 165: 1–13
Spitzer W (1980) Fortsch Med 98: 871–874
Haber P, Burghuber O, Wolf C (1981) Prax Klin Pneumol 39: 719–722
Ziegler WJ, Behrendt R, Dylla S, Grossberger D, Müller C, Wichard F (1983) Medwelt 34: 23–33
Toffel-Nadolny P, Gielsdorf W (1981) Arzneim Forsch 31: 719–722
Merigot P, Garnier R, Efthymiou ML (1985) Ann Pediat 32: 504–511
Mauvernay RY (1966) Neth Pat 6.602.581, zit. nach CA (1967) 66: 55520n
Vejdelek Z, Protiva M (1983) Collect Czech Chem Commun 48: 2977–2988
Elks J (Hrsg.) (1990) Dictionary of Drugs, Chapman and Hall, London, S. 493
Dibbern (Hrsg.) (1978) UV und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf, S. 813
Stern MD (1982) Maturitas 4: 333–339
Mitteilung der Kali-Chemie (1990) Pharmakologische und toxikologische Eigenschaften, Pharmakokinetik und Bioverfügbarkeit konjugierter, natürlicher Östrogene
Grant GA, Beall D (1950) Recent Prog Horm Res 5: 307–334
Stern MD, Givner ML (1978) Studies on the mechanism of action of conjugated equine estrogens. In: Brush MG, King RJB, Taylor RW (Hrsg.) Endometrial Cancer, Bailliere-Tindall, London, S. 309–322
Howard RP, Keaty EC (1971) Arch Int Med 128: 229–234
Stevens RL, Fluharty AL, Killgrove AR, Kihara H (1977) Biochim Biophys Acta 481: 549–560
Bhavnani BR, Woolever CA (1982) J Steroid Biochem 17: 217–223
Bhavnani BR, Sarda IR, Woolever A (1981) J Clin Endocrinol Metab 52: 741–747
Deutsche Gesellschaft für Endokrinologie (1988) Dtsch Aerztebl, Aerztl Mitteilungen 85:3.122–3.125
Surrey ES, Cedars MI (1989) Fertil Steril 52: 36–41
De Cleyn K, Buytaert P, Coppens M (1989) Maturitas 11: 235–242
Myers LS, Dixen J, Morrissette D, Carmichael M, Davidson JM (1990) J Clin Endocrinol Metab 70:1. 124–1. 131
Sonnendecker EWW, Polakow ES (1990) S Afr Med J 77: 281–285
Stomper PC, van Voorhis BJ, Ravnikar VA, Meyer JE (1990) Radiology 174: 487–490
Weinstein L, Bewtra C, Gallagher JC (1990) Am J Obstet Gynecol 162:1. 534–1. 542
Barrett-Connor E, Wingard DL, Criqui MH (1989) JAMA 261:2.095–2.100
Bhatia NN, Bergman A, Karram MM (1989) Am J Obstet Gynecol 160: 176–181
Boucher A, D’Amour P, Hamel L, Fugere P, Gascon-Barre M, Lepage R, Ste-Marie GL (1989) J Clin Endocrinol Metab 68: 831–836
Fraser D, Whitehead MI, Endacott J, Morton J, Ryder TA, Pryse-Davies J (1989) Br J Obstet Gynecol 96: 776–782
Gelfand MM, Ferenczy A (1989) Obstet Gynecol 74: 398–402
Karram MM, Yeko TR, Sauer MV, Bhatia NN (1989) Obstet Gynecol 74: 208–211
Pickett CK, Regensteiner JG, Woodard WD, Hager-man DD, Weil JV, Moore LG (1989) J Appl Physiol 66:1.656–1.661
Ponte CD, Swinker ML, Madhavan S (1989) DICP, Ann Pharmacother 23: 977–979
Regensteiner JG, Hiatt WR, Gyyny RL, Pickett CK, Moore LG (1989) Clin Res 37: 341A
Reginster JY, Sarlet N, Deroisy R, Denis D, Lecart MP, Franchimont P (1989) Rev Med Liege XLIV:55–60
Ross RK, Pike MC, Henderson BE, Mack TM, Lobo RA (1989) Lancet 336: 505
Rubin GL, Peterson HB, Lee NC, Maes EF, Wingo PA, Becker S (1990) Am J Obstet Gynecol 162: 148–154
Sacks FM, Walsh BW, Ravnikar V, Greenberg L, Schiff I (1989) Circulation 80 (Suppl): 329
Sherwin BB, Gelfand MM (1989) Obstet Gynecol 73: 759–766
Sonnendecker EWW, Polakow ES, Benade AJS, Simchowitz E (1989) Am J Obstet Gynecol 160:1. 128–1. 134
Zachgo C, Jürgensen O, Arnold O (1990) Sexualmedizin 1: 34–46
Notelovitz M, Kitchens C, Ware M, Hirschberg K, Conne L (1983) Obstet Gynecol 62: 596–600
Kaufman DW, Miller DR, Rosenberg L, Helmrich SP, Stolley P, Schottenfeld D, Shapiro S (1984) JAMA 252: 63–67
Müller-Brand J (1990) Schweiz Med Wochenschr 120 (18): 676–679
Moffat AC, Clarkes Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London
La Mar GN, Budd DL (1974) J Am Chem Soc 96:7317–7324, zit. nach CA (1975) 82: 4463n
Berman E, Luz Z, Mazur Y, Sheves M (1977) J Org Chem 42:3325–3330, zit. nach CA (1977) 87: 184757c
Drake TGH (1937) Am J Dis Child 53: 754–759
Committee on Nutrition (1963) Pediatrics 31: 512–525
Müller-Schweinitzer E, Weidmann H (1978) Basic pharmacological properties. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds. Handbuch der experimentellen Pharmakologie, Bd. 49, Springer, Berlin Heidelberg New York, S. 87–232
Clark BJ, Chu D, Aeilig WH (1978) Actions on the heart and circulation. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds. Handbuch der experimentellen Pharmakologie, Bd. 49, Springer, Berlin Heidelberg New York, S. 321–420
Loew DM, van Deusen EB, Meier-Ruge W (1978) Effects on the central nervous system. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds. Handbuch der experimentellen Pharmakologie, Bd. 49, Springer, Berlin Heidelberg New York, S. 321–420
Griffith RW, Grauwiler J, Hodel C, Leist KH, Matter B (1978) Toxicological considerations. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds. Handbuch der experimentellen Pharmakologie, Bd. 49, Springer, Berlin Heidelberg New York, S. 805–851
Mar 29, S. 1057
Forth W, Henschler D, Rummel W (Hrsg.) (1987) Allgemeine und spezielle Pharmakologie und Toxikologie, 5.Aufl., Bibliographisches Institut, Brockhaus, Mannheim Wien Zürich
Mutschier E (1981) Arzneimittelwirkungen, Wissenschaftliche Verlagsges, Stuttgart, S. 335–336
Erkkola R (1978) Int J Clin Pharmacol 16: 579–580
Martius J (1983) Gynaekol Praxis 7: 229–234
Leinzinger E (1964) Wien Med Wochenschr 114: 452–459
Saameli K (1978) Effects on the uterus. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds, Chapter IV, Handbook of Experimental Pharmacology, Bd. 49, Springer, Berlin Heidelberg New York, S. 233–319
Griffith RW, Grauwiler J, Hodel C, Leist KH, Matter B (1978) Toxicologic Considerations. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds, Chapter XII, Handbook of Experimental Pharmacology, Bd. 49, Springer, Berlin Heidelberg New York, S. 805–851
Kalkman HO, Neumann V, Brauner V (1989) J Pharm Pharmacol 41: 876–879
Stoll A (1945) Helv Chim Act 28: 1283
Bach NJ, Boaz HE, Kornfeld EC, Chang CJ, Floss HG, Hagaman EW, Wenkert E (1974) J Org Chem 39: 1272
Rall TW (1990) Oxytocin, prostaglandins, ergot alkaloids, and other drugs; tocolytic agents. In: Gilman AG, Rail TW, Nies AS, Taylor P (Hrsg.) The pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto, S. 933–953
Müller-Schweinitzer E (1976) Naunyn-Schmiedeberg’s Arch Pharmacol 295: 41–44
Mercier C (1982) J Pharm Belg 37: 219–227, 289–298
Saxena PR,DenBoer MO (1991) J Neurol 238: S28–S35
Tfelt-Hansen P, Kanstrup IL, Christensen NJ, Winkler K (1983) Clin Sci 65: 599–604
Clark B J (1979) J Pharmacol (Paris) 10: 439–453
Scheife RT, Hills JR (1980) Am J Hosp Pharm 37: 365–374
Perrin VL (1985) Clin Pharmacokin 10: 334–352
Graham JR, Wolff HG (1938) Arch Neurol Psychiat 39: 737–763
Saxena PR (1987) Arteriovenous anastomoses and veins in migraine research. In: Blau JN (Hrsg.) Migraine, clinical, therapeutic, conceptual and research aspects, Chapman and Hall, London, S. 581–596 11. Spierings ELH, Saxena PR (1980) Headache 20: 143–145
Sakai F, Meyer JS (1978) Headache 18: 122–132
Kanto J (1983) Int J Clin Pharmacol Ther Tox 21: 135–142
Aellig WH, Nüesch E (1977) Int J Clin Pharmacol Ther Tox 15: 106–112
Ibraheem JJ, Paalzow L, Tfelt-Hansen P (1983) Br J Clin Pharmacol 16: 695–699
Sanders SW, Haering N, Mosberg H, Jaeger H (1986) Eur J Clin Pharmacol 30: 331–334
Waldenlind E, Ekbom K, Krabbe AE, Paalzow G, Paalzow L, Tfelt-Hansen P (1982) Acta Neurol Scand 65 (Suppl90): 83–84
Ibraheem JJ, Paalzow L, Tfelt-Hansen P (1985) Eur J Clin Pharmacol 29: 61–66
Tfelt-Hansen P, Paalzow L (1985) Clin Pharmacol Ther 37: 29–35
Ibraheem JJ, Paalzow L, Tfelt-Hansen P (1982) Eur J Clin Pharmacol 23: 235–240
Nimmerfall F, Rosenthaler J (1976) J Pharmacokin Biopharm 4: 57–66
Krupp P, Haas G (1979) J Pharmacol (Paris) 10: 401–412
Ala-Hurula V (1982) Eur J Clin Pharmacol 21: 397–402
Chobanian AV, Tifft CP, Faxon DP, Creager MA, Sakkel H (1983) Circulation 67: 602–609
Biaggioni I, Zygmunt D, Haile V, Robertson D (1990) Am J Cardiol 65: 89–92
Creutzig A, Alexander K (1985) Dtsch Med Wochenschr 110:1. 420–1. 422
Schulz V (1984) Fortschr Med 102: 189–191
Carliner NH, Denune DP, Finch CS jr, Goldberg LI (1974) JAMA 227: 308–309
Popov N (1982) Z Aerztl Fortbild 76: 624–633
Lietman PS (1986) J Pediat 108: 824–829
Witte W, Dünnhaupt K, Rische H (1982) Dtsch Gesundheitswes 37:2. 054–2. 058
Kresken M, Wiedemann B (1987) Infection 15 (Suppl4): S150–S157
Witte W, Spencker FB, Halle E (1987) Z Klin Med 42: 31–36
Raab W (1988) Med Welt 39:1. 579–1. 581
Gordin A, Lehtola J, Jauhonen P, Kesäniemi A, Wikberg R (1989) Erythromycin shortens transit time in healthy volunteers. I V. World Conference on Clinical Pharmacology and Therapeutics, Mannheim Heidelberg
Hovi T, Josefsson K, Renkonen OV (1983) Eur J Clin Pharmacol 25: 271–273
McCracken GH, Ginsburg CM, Clahsen JC, Thomas ML (1978) Pediatrics 62: 738–743
De Bernardi M, Feletti F, Gazzani G, Fregnan GB (1988) Int J Clin Pharmacol Ther Tox 26: 444–447
Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban & Schwarzenberg, München Wien Baltimore, S. 217–223
Mar 28 (1982) S. 1. 158–1. 164
Disse B, Gundert-Remy U, Weber E, Andrassy K, Sietzen W, Lang A (1986) Int J Clin Pharmacol Ther Tox 24: 460–464
Kanfer A, Stamatakis G, Torlotin JC, Fredj G, Kenouch S, Mery JP (1987) Clin Nephrol 27: 147–150
Iliopoulou A, Downey K, Chaput De Saintogne DM, Turner P (1982) Eur J Clin Pharmacol 23: 435–440
Barre J, Mallat A, Rosenbaum J, Deforges L, Houin G, Dhumeaux D, Tillement JP (1987) Br J Clin Pharmacol 23: 753–757
Downey KM, Chaput De Saintogne DM (1986) Br J Clin Pharmacol 21: 295–299
Rutland J, Berend N, Marlin GE (1979) Br J Clin Pharmacol 8: 343–347
Hovi T, Heikinheimo M (1985) Eur J Clin Pharmacol 28: 231–233
Prandota J, Tillement JP, D’Athis P, Campos H, Barre J (1980) J Int Med Res 8 (Suppl 2): 1–8
Kozak PP, Cummins LH, Gillman SA (1977) J Allergy Clin Immunol 60: 149–151
Renton KW, Gray JD, Hung OR (1981) Clin Pharmacol Ther 30: 422–426
Iliopoulou A, Aldhous ME, Johnston A, Turner P (1982) Br J Clin Pharmacol 14: 495–499
Paulsen O, Höglund P, Nilsson LG, Bengtsson HI (1987) Eur J Clin Pharmacol 32: 493–498
Goulden KJ, Camfield P, Dolley JM, Fraser A, Meek DC, Renton KW, Tibbles JAR (1986) J Pediat 109: 135–138
Zitelli BJ, Howrie DL, Altman H, Maroon TJ (1987) Clin Pediat 26: 117–119
Maxwell DL, Gilmour-White SK, Hall MR (1989) Br Med J 298: 572
Freeman DJ, Martell R, Carruthers SG, Heinrichs D, Keown PA, Stiller CR (1987) Br J Clin Pharmacol 23: 776–778
Milne RW, Coulthard K, Nation RL, Penna AC, Roberts G, Sansom LN (1988) Br J Clin Pharmacol 26: 330–333
Giuliani FC, Kaplan NO (1980) Cancer Res 40:4. 682–4. 687
Giuliani FC, Zirvi KA, Kaplan NO (1981) Int J Cancer 27: 5–13
Casazza AM, Savi G, Pratesi G, Di Marco A (1983) Eur J Cancer Clin Oncol 19: 411–418
Ferrari L, Brambilla C, Rossi A, Bonfante V, Villani F, Grippa F, Bonadonna G (1983) 4’-deoxydoxorubicin (dxDx): The experience of the Instituto Nazionale Tumori. Fourth NCI-EORTC Symposium on New Drugs in Cancer Therapy, Abstr. 18, Brussels, Dec 14–17
Pratesi G, Deschner EE (1984) Cancer 56: 18–24
Salmon SE, Liu RM, Casazza AM (1981) Cancer Chemother Pharmacol 6: 103–110
Belvedere G, Suarato A, Geroni C, Giuliani F, D’Incalci M (1989) Biochem Pharmacol 38:3. 713–3. 721
Dickinson AC, DeJordy JO, Boutin MG (1984) Biochem Biophys Res Commun 125: 584–591
Dodion P, Davis TA, Rozencweig M (1985) Invest New Drugs 3: 361–368
Tamassia V, Goldaniga GC, Moro E, Pacciarini MA, Stegnjaich S, Piazza E (1983) Human pharmacokinetic studies on three new anthracyclines: Epirubicin, Idarubicin, Esorubicin. Fourth NCI-EORTC Symposium on New Drugs in Cancer Therapy, Abstr. 13, Brussels, Dec 14–17
Formelli F, Pollini C, Casazza AM (1981) Cancer Chemother Pharmacol 5: 139–144
Stanton GF, Raymond V, Wittes RE (1985) Cancer Res 45:1. 862–1. 868
Le Bot MA, Begue JM, Kernaleguen D, Roberts J, Ratanasavanh D, Airiau J, Riche C, Guillouzo A (1988) Biochem Pharmacol 37:3. 877–3. 887
Rozencweig M, Crespeigne N, Kenis Y (1983) Invest New Drugs 1: 309–313
Ferrari L, Rossi A, Brambilla C (1984) Invest New Drugs 2: 287–295
Sessa C, Bosia L, Kaplan S, Pusteria C, Varini M, Cavalli F (1984) Invest New Drugs 2: 369–374
Weiss RB, Sarosy G, Clagett-Carr K, Russo M, Leyland-Jones B (1986) Cancer Chemother Pharmacol 18: 185–197
Garewal HS, Robertone A, Salmon SE (1984) J Clin Oncol 2:1. 034–1. 039
Zagonel V, Tirelli U, Vaccher E, Sorio R, Saracchini S, Monfardini S (1987) Invest New Drugs 5: 123
Holdener EE, Cavalli F, Hansen HH (1985) Proc Am Soc Clin Oncol 4: 93
Fiore J, Kemeny N, Raymond V, Young C (1986) Cancer Treat Rep 70:1. 241–1. 242
Locker GY, Hoeltgen T, Kilton L (1987) Cancer Treat Rep 71: 765–766
Leitner SP, Casper ES, Hakes TB (1985) Cancer Treat Rep 69:1. 319–1. 320
Carlson RW, Billingham ME, Kohler M, Johnson FD, Doroshow JH, Torti FM (1987) Cancer Treat Rep 71: 427–428
Rankin EM, Knight RK, Rubens RD (1987) Invest New Drugs 5: 124
Kaplan S, Sessa C, Joss R, Obrecht JP, Siegenthaler P, Cavalli F (1985) Cancer Treat Rep 69:1. 337–1. 338
Ringenberg S, Propert K, Perry M (1986) Proc Am Soc Clin Oncol 5: 174
Rose C, Lad T, Kilton L, Rosen S, Rossof A, Blough R (1987) Proc Am Soc Clin Oncol 6: 176
Kish J, Ensley J, Tapazoglou E, Al-Sarraf M (1986) Proc Am Soc Clin Oncol 5: 106
Williams RD, Torti FM, Carlson RW, Hannigan J, Paylos CC, Billingham ME (1986) Proc Am Soc Clin Oncol 5: 109
Blayney DW, Leong LA, Goldberg DA (1986) Proc Am Soc Cancer Res 27: 179
Braich T, Ahman FR, Garewal HS, Robertone A, Salmon SE (1986) Invest New Drugs 4: 193–196
Green MD, Speyer IL, Werntz JC (1990) Invest New Drugs 8: 333–336
Frustacci S, Gasparini G, Gallignoni E, Veronesi A, Tirelli U, Monfardini S (1987) Invest New Drugs 5: 124
Casazza AM, Di Marco A, Bonadonna G, Bonfante V, Bertaozzoli C, Bellini O, Pratesi G, Sala L, Ballerini L (1980) Effects of modifications in position 4 of the chromophore or in position 4’ of the aminosugar, on the antitumor activity and toxicity of daunorubicin and doxorubicin. In: Crooke ST, Reich SD (Hrsg.) Anthracyclines: current status and new developments, Academic Press, New York London Toronto Sydney San Francisco, S. 403–430
Bertazzoli C, Sammartini U, Balconi F, Roverno C, Nasini A, Dell’Oro I, Antongiovanni V, Tosana MG, Lux B (1982) Experimental toxicology of 4’-deoxydo-xorubicin, Proc 13th Int Cancer Congress, Sept. 8–15, Seattle, USA, S. 407
Carlson RW, Williams RD, Billingham ME, Pavlos CL, Hannigan JF, Kohler M, Torti FM (1986) Am Ass Clin Oncol 5: 52
Bonfante V, Rossi A, Brambilla C (1985) Proc Am Soc Cancer Res 26: 165
Muggia FM, Green MD (1991) Crit Rev Oncol Hematol 11: 43–64
Lee KM, Dorr RT, Robertone A (1987) Invest New Drugs 5: 31–35
Moeschlin S (1986) Klinik und Therapie der Vergiftungen, 7. Aufl., Georg Thieme Verlag, Stuttgart New York, S. 271
Kuschinsky G, Lüllmann H (1987) Kurzes Lehrbuch der Pharmakologie und Toxikologie, 11. Aufl., Georg Thieme Verlag, Stuttgart New York, S. 522
Marcy SM (1985) Pediat Infect Dis 4: 192–201
Gilman AG, Goodman LS, Rall TW, Murad F (1988) Goodman and Gilman’s The pharmacogical basis of therapeutics, 7. Aufl., Macmillan, New York, S. 951
Harper WES (1981) Br J Urol 53: 433–438
Diamond SM, Henrich WL (1987) Am J Kidney Dis 9: 3–11
Veech (1988) Kidney Int 34: 587–599
Goodman G, Gilman A (1941) The pharmacogical basis of therapeutics, Macmillan, New York, S. 816
Powell DW (1986) Ion and water transport in the intestine. In: Andreoli TE, Hoffman JE, Fanestil DD, Schultz SG (Hrsg.) Physiology of membrane diseases, 2. Aufl., Plenum, New York London, S. 750
Weiner MW (1982) Artif Organs 6: 370–377
Kuschinsky G, Lüllmann H (1987) Kurzes Lehrbuch der Pharmakologie und Toxikologie, 11. Aufl., Georg Thieme Verlag, Stuttgart New York, S. 297
Campese VM (1988) Kidney Int 33 (Suppl24): S186–S190
Mar 29, S. 1.537
Oettel M, Schubert K (1985) Steroidhormone. In: Markwardt F, Matthies H, Oelssner W (Hrsg.) Medizinische Pharmakologie, Bd. II, Thieme, Leipzig, S. 710–716
Kopera H (1980) Pharmatherapeutica 2: 16–28
Berry M, Metzger D, Chambon P (1990) EMBO J 9:2.811–2.818
Maass H (1988) Gynecol 6: 33–34
Lauritzen C (1975) Acta Obstet Gynecol Scand 51 (Suppl): 47–61
Fink BJ, Christensen MS (1981) Maturitas 3: 289–294
Adlercreutz H, Martin F, Järvenpää P, Fotsis T (1979) Contraception 20: 201–223
Dunn JF, Nisula BC, Rodbard D (1981) J Clin Endocrinol Metab 53: 58–68
Siddle N, Campbell S, Whitehead M (1982) Therapeutic strategies: Oestrogen supplementation. In: Fioretti P, Martini L, Melis GB, Yen SSC (Hrsg.) The Menopause: Clinical, Endocrinological and Pathophysiological Aspects, Serono Symposium No. 39, Academic Press, London New York, S. 487–501
Wright F, Mauvais-Jarvis P (1989) Metabolism of sex steroids. In: Greaves MW, Shuster S (Hrsg.) Pharmacology of the Skin I, Handbook of Experimental Pharmacology, Bd. 87/II, Springer, Heidelberg New York London Paris Tokyo, S. 247–254
Schaefer H, Zesch A, Stüttgen G (1982) Skin permeability, Springer, Berlin Heidelberg New York
Lievertz RW (1987) Am J Obstet Gynecol 156:1. 289–1. 293
Bush TL, Cowan LD, Barrett-Connor E, Criqui MH, Karon JM, Wallace RB, Tyroler HA, Rifkind BM (1983) JAMA 249: 903–906
Fachinformation Estrifam/Estrifam forte der Fa. Novo (1990)
Fachinformation Cyclo-Progynova der Fa. Schering (1987)
Niculescu-Duvaz I, Cambanis A, Tarnauceanu E (1967) J Med Chem 10: 172–174
Kadohama N, Kirdani RY, Murphy GP, Sandberg AA (1978) J Urol 119: 235–239
Kadohama N, Kirdani RY, Madajewitz S, Murphy GP, Sandberg A (1979) NY State J Med 79:1. 005–1. 009
Gunnarsson PO, Andersson SB, Johansson SA, Nilsson T, Plym-Forshell G (1984) Eur J Clin Pharmacol 26: 113–9
Tritsch GL, Shukla SK, Mittelmann A, Murphy GP (1974) Invest Urol 12: 38–39
Gunnarsson PO, Forshell G, Fritjofsson A, Norlen BJ (1981) Scand J Urol Nephrol 15: 201–206
Kirdani RY, Mittelman A, Murphy GP, Sandberg AA (1975) J Clin Endocrinol Metab 41: 305–318
Jönsson G, Olsson AM, Luttrop W (1975) Vitamins Hormones 33: 351–376
Tew KD (1983) Sem Oncol 10: (3) 21–26
Tew KD, Hartley-Asp B (1984) Urology 23: 28–33
Ahlgren JD, Scjein PS (1983) Sem Oncol 10:(3)46–47
Lopez R, Karakonsis CP, Didolkar MS, Holyoke ED (1978) Cancer Treat Rep 62:1. 329–1. 332
Müntzing J, Jensen G, Högberg B (1979) Acta Pharmacol Toxicol 44: 1–6
Hartley-Asp B, Gunnarsson PO (1982) J Urol 127: 818–822
Hartley-Asp B (1984) The Prostate 5: 93–100
Tew KD, Stearns ME (1987) Urol Res 15: 155–160
Dixon R, Brooks M, Gill G (1980) Res Commun Pathol Pharmacol 27: 17–29
Andersson SB, Gunnarsson PO, Nilsson T, Forshell GP (1981) Eur J Drug Metab Pharmacokin 6: 149–154
Plym Forshell G, Müntzing J, Ek A, Lindstedt E, Dencker H (1976) Invest Urol 14: 128–131
Gunnarsson PO, Andersson SB, Johansson S A, Nilsson T, Forshell G (1984) Eur J Clin Pharmacol 26: 113–119
Sandberg AA (1983) Sem Oncol 10: 3–15
Plym Forshell G, Nilsson H (1974) Acta Pharmacol Toxicol 35 (Suppl 1): 28
Björk P, Forsgren B, Gustafsson JA, Gustafsson JA, Pousette A, Högberg B (1982) Cancer Res 42:1. 935–1. 942
Norlen BJ (1988) J Urol 140:1. 058–1. 062
Müntzing J, Gunarsson K (1984) Urology, 23, 6 (Suppl June): 6–10
Byar DP (1973) Cancer 32:1. 126–1. 130
Smith PH, Suciu S, Robinson MRG, Richards B, Bastable JR, Glashan RW, Bonffioux C, Lardennois B, Williams RE, de Pauw M (1986) J Urol 136: 619–623
Benson RC, Gill GM, Cummings KB (1983) Sem Oncol 10: 43–45
Kühn M (1990) Estracyt — clinical developments. 2nd International Symposium on recent advances in urological cancer, Paris, 27.–29. Juni
Andersson L, Edsmyr F, Könyves I (1983) Estramustine and prednimustine. In: Pavone-Macaluso M, Smith PH (Hrsg.) Cancer of the Prostate and Kidney, Plenum Press, New York, S. 359–363
Fossa SD, Miller A (1976) J Urol 115: 406–408
Chrisholm GP, O’Donaghue EPN, Kennedy CL (1977) Brit J Urol 49: 717–720
Nilsson T, Jönsson G (1976) J Urol 115: 168–169
Nagel R, Kölln CP (1977) Brit J Urol 49: 73–79
Leistenschneider W, Nagel R(1980) Eur Urol 6:111–115
Soloway MS, de Kernion JB, Gibbons RP, Johnson DE, Loening SA, Pontes JE, Pront GR, Schmidt JD, Scott WW, Chu TM (1981) J Urol 125: 664–667
Roberts G, Gallagher B, Jones RN (1958) Infrared Absorption Spectra of Steroids, Interscience Publ, New York
Pschyrembel W, Strauss G, Petri E (1991) Praktische Gynäkologie für Studium, Klinik und Praxis, 5. Aufl., de Gruyter, Berlin New York, S. 418–571
Haskins AL, Moszkowski EF, Whitelock VP (1968) Am J Obstet Gynecol 102: 665–670
Miller BG (1969) J Endocrinol 43: 563–570
Vähäpassi J, Adlercreutz H (1975) Contraception 11: 427–440
van der Vies J (1982) Maturitas 4: 291–299
Clark JH, Markaverich BM (1983) Pharmacol Ther 21: 429–453
Adlercreutz H, Martin F, Järvenpää P, Fotsis T (1979) Contraception 20: 201–223
Dunn JF, Nisula BC, Rodbard D (1981) J Clin Endocrinol Metab 53: 58–68
Siegers CP (1984) Med Monatsschr Pharm 7: 329–334
Rauramo L, Punnonen R, Kaihola HL, Grönroos M (1978) Maturitas 1: 71–78
Stoa KF, Levitz M (1968) Acta Endocrinol 57: 657–668
Englund DE, Elamsson KB, Johansson EDB (1982) Act Endoer 99: 136–140
Bergink EW (1980) Acta Endocrinol 233 (Suppl): 9–16
Fink BJ, Christensen MS (1981) Maturitas 3: 289–294
Flood C, Pratt JH, Longcope C (1976) J Clin Endocrinol Metab 42: 1–8
Kopera H (1983) Actions and potencies of estriol in the human. In: Jasonni VM (Hrsg.) Steroids and Endometrial Cancer, Raven Press, New York, S. 175–184
Fachinformation Ortho-Gynest der Fa. Cilag (1990)
Lauritzen C (Hrsg.) (1987) Klinik der Frauenheilkunde und Geburtshilfe, Bd.l, Gynäkologische Endokrinologie, Urban & Schwarzenberg, München Wien Baltimore, S. 157–159
Haskins AL, Moszkowski EF, Whitelock VP (1968) Am J Obstet Gynecol 102: 665–669
Mar28, S. 1.429–1.430
Schrage R (1984) Therapie des klimakterischen Syndroms, Verlag Chemie, Weinheim, S. 60
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Schultz EM, Cragoe EJ jr, Bicking JB, Bollhofer WA, Sprague JM (1962) J Med Pharm Chem 5: 660–662
Beyer KH, Baer JE, Michaelson JK, Russo HF (1965) J Pharmacol Exp Ther 147: 1–22
Peters G, Roch-Ramel F (1969) Ethacrynic acid and related drugs. In: Herken H (Hrsg.) Handb Exp Pharmacol, Diuretica, Springer, Berlin Heidelberg New York (Verlag?), 34: 406–435
Greger R, Wangemann P (1987) Renal Physiol 10: 198–220
Sutton RAL (1985) Am J Kidn Dis 5: 4–9
Weiner IM (1990) Diuretics and other agents employed in the mobilization of edema fluid. In: Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 8. Aufl., The MacMillan Company, New York, S. 713–731
Jenny M, De Souse RC (1966) J Urol Nephrol 72: 569–579
Bosch JP, Goldstein MH, Levitt MF (1977) Am J Physiol 232: F397–F404
Senft G, Losert W, Lübbemeier A (1968) Arzneim Forsch 18: 563–566
Garay RP, Hannaert PA, Nazaret C, Cragoe EJ jr (1986) Naunyn-Schmiedeberg’s Arch Pharmacol 334: 202–209
Tosco M, Orsenigo MN, Esporito G, Faelli A (1988) Proc Soc Exp Biol Med 188: 122–127
Tanaka T, Inagaki C, Kunugi Y, Takaori S (1987) Jap J Pharmacol 43: 205–212
Shiroya T, Fukunaga R, Akashi K, Shimada N, Tagaki Y, Nishino T, Hara M, Inagaki C (1989) J Biol Chem 264:1. 716–1. 721
Vessey DA, Boyer TD (1988) Toxicol Appl Pharmacol 93: 275–280
Ploemen JH, van Ommen B, van Bladeren PJ (1990) Biochem Pharmacol 40:1. 631–1. 635
Pascoe GA, Olafsdottir K, Reed DJ (1987) Arch Biochem Biophys 256: 150–158
Lebedev AA (1990) Farmakol Toksikol 53: 8–13
Miyanoshita A, Terada H, Endou H (1989) J Pharmacol Exp Ther 251:1. 155–1. 159
Bugge JF (1989) J Oslo City Hosp 39: 123–136
Bugge JF, Stokke ES, Viske A, Kiil F (1990) Acta Physiol Scand 138: 193–201
Park CS, Doh PS, Carraway RE, Chung GG, Fray JC, Miller TB (1990) Am J Physiol 259: F539–F544
Martinez-Maldonano M, Gely R, Tapia E, Benabe JE (1990) Hypertension 16: 261–268
Gruetter CA, Lemke SM (1986) Can J Physiol Pharmacol 64:1. 395–1. 401
Rapaport RM, Murad F (1988) Gen Pharmacol 19: 61–65
Okolicsanyi L, Lirussi F, Strazzabosco M, Jemmolo RM, Orlando R, Nassuato G, Muraca M, Crepaldi G (1986) Drugs 31: 430–448
Rybak LP (1988) J Laryngol Otol 102: 518–520
Erwall C, Friberg U, Bagger-Sjoback D, Rask-Andersen H (1988) Orl J Otorhinolaryngol Relat Spec 50: 42–53
Rybak LP, Whitworth C (1988) Am J Otolaryngol 9: 238–248
Leung KH (1988) Cell Immunol 114: 359–369
Patwa DC, Abraham DJ, Hung TC (1987) Blood Cells 12: 589–601
Natochin IUN, Raznik LV, Bakhteeva VT, Ivanov VB, Miazina EM (1986) Bull Eksp Biol Med 102: 442–445
APr
Fehske KJ, Müller WE (1986) Pharmacology 32: 208–213
Shirey RS, Bartholomew J, Bell W, Pollack B, Kickler TS, Ness PM (1988) Transfusion 28: 70–72
Sherlock S, Senewiratne B, Scott A, Walker JG (1966) Lancet I:1. 049–1. 053
Bruijn JA, van Albada Knipers GA, Smit VT, Euldernik F (1986) Scand J Rheumatol 15: 363–367
Mallory A, Kern F (1988) Baillieres Clin Gastroenterol 2: 293–307
US2234933 (1938) Beil, Bd. 13/III, S. 1728
Ueda T, Toyoshima S, Takahashi K, Muraola M (1985) Pharm Bull (Tokyo) 3: 465–468
Shita A, Keil F (1930) Chem Ber 63: 34–50
In: Moffat AC (Hrsg.) (1968) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press London, S. 589
In: Hansch CD (Hrsg.) (1990) Comprehensive Medicinal Chemistry, Pergamon Press, Oxford, Bd. 6, S. 507
Abdel Kader MA, Taha AM (1978) J Pharm Pharmacol 30 (Suppl.): 68 p
Rendic C (1989) Acta Pharm Jugosl 39: 173–180
Eiden F, Khammash G (1972) Pharm Ztg 117: 1994–1998
Eiden F, Khammash G (1973) Pharm Ztg 118: 635–645
Musumarra G, Scarlata G, Cirma G, Romano G, Palazzo S, Clementi S, Giulietta G (1985) J Chromatogr 350 (1): 151–168
Hapke HJ, Sterner W (1968) Arzneim Forsch 10:1. 664–1. 672
Hashimoto K, Satoh H, Imai S (1979) J Cardiovasc Pharmacol 1: 561–570
Hochrein H, Kukoretz WR (Hrsg) (1972) Therapie der koronaren Herzkrankheit. Verlag Gerhard Witzstrock, Baden-Baden, Brüssel
Amos K, Auterhoff H (1979) Dtsch Apoth Ztg 119 (37):1. 440–1. 442
Klosa J (1955) Arch Pharm 288: 301–303
DE 870109 (1950), CA (1954) 48: 10779
Bram G, Bensaid Y, Combet-Farnoux C, Galons H, Miocque M (1986) Pharmazie 41: 431
Taha AM, Abd El-Kader MA (1979) J Chromatogr 177: 405–408
Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr 323: 191–225
Arranz Pena MI, Saenz Lope E (1988) J Clin Chem Clin Biochem 26: 791–793
Vasquez C, Labayru T, Rodriguez-Soriano J (1984) Lancet i:914–915
Zmojdzin A (1983) Pol. PL 121, 760; zit. nach CA 101: 60131g
Wang X, Zeng B (1987) Yaowu Fenxi Zazhi, 7:150–152; zit. nach CA 107:121199h
Ma J, Liu Y (1984) Yaowu Fenxi Zazhi, 4:209–212; zit. nach CA 101:157775h
Ma J (1983) Yaowu Fenxi Zazhi, 3:329–332; zit. nach CA 100: 56945n
Zhao H (1981) Yaoxue Tongbao, 16:25; zit. nach CA 96: 11570u
Fu E, Jing S (1982) Yaoxue Tongbao, 17:662–663; zit. nach CA 98: 78029j
Koshiro A, Ishimoto K, Uchida E, Fukui M, Ogata T (1979) Kyushu Yakugakkai Kaiho, (33):55–62; zit. nach CA 92:185799h
Yu W, Wang L, Yang G (1986) Huaxi Yike Daxue Xuebao 17:51–53; zit. nach CA 105: 1 2001a
Bogdanova S, Nikova T, Minkov E, Shekerdzhiiski R (1988) Farmatsiya, 38:32–37; zit. nach CA 109:134909f
Koroleva NA, Levchuk TA, Vavilova NV, Altukhova LB, Morozova VA, Volkova NS, Granik EM, Ukolova ZI, Shashkina LF, Golubeva MI (1983) Khim-Farm Zh 17:731–734; zit. nach CA 99:128256z
Tentsova AI, Altukhova LB, Orabi Abu Shaaban Valid, Kharitonova SI, Trakman YG, Ulasevich AS (1984) Farmatsiya 33:27–30; zit. nach CA 101: 1 2128q
Zmojdzin A (1983) Pol. PL 122, 497; zit. nach CA 104: 129627e
Ribalta Baro JM (1989) Span. ES 2,005,425; zit. nach CA 112: 157865q
Mar 29, S. 1.133
Harrison RF, Matthews T (1984) Lancet II: 296
Benson JWT, Hayward C, Osborne JP, Schulte JF, Drayton MR, Murphy JF, Rennie JM, Speidel BD, Cookie RW (1986) Lancet II:1. 297–1. 300
Morgan MEI, Benson JWT, Cooke RWI (1981) Lancet II: 830–831
Yalcindag ON, Onur E (1973) Sci Pharm 41: 334
Messerschmidt W (1992) Pharm Ztg 137: 964–968
Ebel S (1977) Handbuch der Arzneimittelanalytik, Verlag Chemie, Weinheim, S. 214
Monographie Ethacridin/ Ethacridinlactat. (1988), BAnz 191. 4469
Krasilnikow AP, Adartschenko AA (1987) Resistenzentwicklung von Staph, aureus, Pseud. aeruginosa und Enterobacteriaceae gegen Antiseptika. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Handbuch der Antiseptik, Bd.II/3, Antibakterielle, antifungielle und antivirale Antiseptik — ausgewählte Wirkstoffe, Volk und Gesundheit, Berlin, S. 123–142
Kalinke J, Baumann B, Sziesenitz E, Großer J, Prickler H, Kalinke T (1984) Einfluß antiseptischer Maßnahmen auf die Mundhöhlenflora. In: Winkler H, Kramer A (Hrsg.) Fortschritte in der Krankenhaushygiene — Sterilisation, Desinfektion, Keimzahlverminderung, Barth, Leipzig (Schriftenreihe Mikrobielle Umwelt und antimikrobielle Maßnahmen, Bd. 9 ), S. 238–240
Schubert H, Berowa N, Hegyi E, Jirasek L, Kalensky J, Korossy S, Michialow P, Nebenführer L, Prater E, Rothe A, Rudzki E, Temesvari E, Ziegler V, Zschunke E (1982) Derm Monatsschr 168: 613–623
Kramer A, Nasemann TRK, Pambor M (1993) Antiseptik aus dermatologischer Indikation. In: Kramer A, Gröschel D, Heeg P, Hingst V, Lippert H, Rotter M, Weuffen W (Hrsg.) Klinische Anwendung von Antiseptika, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest, S. 371–400
Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 142–145
Girgis EH, Gad Z, Maram M (1974) J Pharm Sci 63:1. 764–1. 767
Wade A (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 592
Calo A, Cardini C, Quercia V (1968) J Chromatogr 37: 194–196
Richard BM, Manno JE, Manno BR (1974) J Chromatogr 89: 80–83
Tju Lik Ng (1982) J Chromatogr Sci 20: 479–482
Karlson AG (1961) Am Rev Resp Dis 84: 905–906
Bönicke R (1962) Beitr Klin Tuberk 126: 108–117
Lucchesi M (1975) Vortr XXIIIrd Conf Internatl Union against Tuberc, Mexico City, Sept 22–26
Lukas W (1975) Vortr XXIIIrd Conf Internatl Union against Tuberc, Mexico City, Sept 22–26
Lutz A, Berger MA (1962) Presse Méd 70: 1. 317
Delaude A, Albarède JL (1972) Gaz Méd France 79:7. 301–7. 305
Sors C, Grosset J (1972) Gaz Méd France 79: 7. 360
Birnberger A, Stelter WJ, Berbig R (1982) Therapiewoche 32:6. 464–6. 468
Gale GR, McLain HH (1963) J Bacteriol 86: 749
Forbes M, Kuck NA, Peets EA (1962) J Bacteriol 84:1. 099–1. 101
Kuck NA, Peets EA, Forbes M (1963) Am Rev Resp Dis 87: 905–906
Forbes M, Peets EA, Kuck NA (1966) Ann NY Acad Sci 135: 726–728
Tsukamura M, Mizuno S (1973) Kekkaku 42: 437
Place VA, Thomas JP (1963) Am Rev Resp Dis 87: 901–904
Dume T, Wagner C, Wetzels E (1971) Dtsch Med Wochenschr 98:1. 430–1. 434
Strauss I, Erhardt F (1970) Chemotherapy 15: 148–157
Place VA, Peets EA, Buyske DA, Little RR (1966) Ann NY Acad Sci 135: 775–795
Lee CS, Brater DC, Gambertoglio JG, Benet LZ (1980) J Pharmacokin Biopharma 8: 335–346
Pujet JC, Pujet C (1972) Gaz Méd France 79, Suppl:7. 312–7. 316
Gundert-Remy U, Klett M, Weber E (1973) Eur J Clin Pharmacol 6: 133–136
Coury C, Delepierre F (1972) Gaz Méd France 79: 7. 317
Djurovic V, Decroix G, Daumet P (1973) Presse Méd 2:2. 815–2. 816
Pilheu JA, Maglio F, Cetrángolo R, Pleus AD (1971) Tubercle 52: 117–122
Place VA, Pyle MM, de la Huerga J (1969) Am Rev Resp Dis 99: 783–785
König K (1970) Habil-Schrift, Homburg/Saar
Peets EA, Sweeney WM, Place VA, Buyske DA (1965) Am Rev Resp Dis 91: 51–58
Arnaud G, Gavend M, Roulet A, Paramelle B, Bessard G (1972) Gaz Méd France 79: 7. 321
Christopher TG, Blair A, Forrey A, Cutler RE (1973) Proc Dialysis Transplant Forum 96–100
Strauss I (1969) Therapiewoche 19: 81
Zeller F, Róka L (1973) Prax Pneumol 27: 36–43
Pyle MM (1969) Tubercle, Suppl 67: 30–32
Pyle MM, Pfuetze KH, Pearlman MD, de la Huerga J, Hubble RH (1966) Am Rev Resp Dis 93: 428–441
Groß V, Eule H, Hager G (1973) Klin Mbl Augenheilk 163: 17–22
Pernod J, Souquet R, Batime J, Jospin G, Lerest FP (1971) J Therapeut 2: 53–57
Hussels H, Otto HS (1971) Pneumologie 145: 392–396
Oka S, Konno K, Kudo S, Munaka K, Yamagushi S, Ohizumi K (1965) Am Rev Resp Dis 91: 762–763
Agrawal R (1969) Br Med J IV: 540
Bobrowitz ID, Gokulanathan KS (1965) Dis Chest 48: 239–250
Carr RE, Henkind P (1962) Arch Ophthal (Chicago) 67: 566–571
Leibold JE (1966) Ann NY Acad Sci 135: 904–909
Bruckschen E (1976) Myambutol. Experimentelle und klinische Ergebnisse, 3. Aufl., Arneim Forsch, 20. Beiheft, Editio Cantor, Aulendorf, S. 137
Boman G, Calissendorf B (1974) Scand J Resp Dis 55: 176–180
Reimers D (1972) Prax Pneumol 26: 445–449
Tugwell P, James SL (1972) Postgrad Med J 48: 667–670
Postlethwaite AE, Bartel AG, Kelley WN (1962) New Engl J Med 286: 761–762
Postlethwaite AE, Kelley WN (1972) Arth Rheum 15: 403
Matthiessen W, Wundschock M, Radenbach KL, Göbel D, Jungbluth H, Kropp R (1979) Prax Pneumol 33:1. 109–1. 114
Stone WJ, Waldron JA, Dixon JH jr, Primm RK, Horn RG (1975) Antimicrob Agents Chemother 10: 164–172
US Publ Health Service Tuberculosis therapy trial (1968) Am Rev Resp Dis 98: 825–836
Rabinovitz M, Pitlik SD, Halvey J, Rosenfeld JB (1982) Chest 81: 765–766
Bobrowitz ID (1974) Chest 66: 20–24
Lewit T, Nebel L, Terracina S, Karman S (1974) Chest 66: 25–26
Wade A (1986) Clarke’s Isolation and Identification of Drugs, 2.Aufl., The Pharmaceutical Press, London, S. 592
Wilkinson RG, Shepherd RG, Thomas JP, Baughn C (1961) J Am Chem Soc 83: 2212–2213
Wilkinson RG, Shepherd RG, Cantrall MB (1962) J Med Chem 5: 823–835
Shepherd RG, Baughn C, Cantrall ML, Goodstein B, Thomas JP, Wilkinson RG (1966) Ann NY Acad Sci 135: 686
Kanther R (1970) Antibiot Chemother 16: 203
Strauss I, Erhardt F (1979) Chemotherapy 15: 148
Lee CS, Benet LZ (1976) J Chromatogr 128: 188
Lee CS, Benet LZ (1978) J Pharm Sci 67: 470–473
Lee CS, Wang LH (1980) J Pharm Sci 69: 362–363
Holdiness MR, Israili ZH, Justice JB (1981) J Chromatogr 224: 415–422
Gamberini G, Ferioli V, Cameroni R, Bernabei MT (1984) Atti Soc Nat Mat Modena 115: 15–23
Gamberini G, Ferioli V (1988) Farmaco 43 (11): 357–363
Weijlard J, Swanzey EF, Tashjian E (1949) J Am Chem Soc 71: 1889–1890
Galat A (1951) J Am Chem Soc 73: 3654–3656
Dobrowsky A (1951) Monatsh 82: 122–139
Yalcindag ON, Onur E (1968) Bull Soc Pharm Bordeaux 107: 31–37
Depovere MMP, Piraux M (1975) Bull Soc Pharm Bordeaux 114: 47–51
Szendey GL (1969) Fresenius Z Anal Chem 244: 257
Daldrup T, Susanto F, Michalke P (1981) Z Anal Chem 308: 413–427
Daltrup T, Michalke P, Boehme W (1982) Chromatography Newsletter 10: 1–7
Surmann P (1987) Quantitative Analyse von Arzneistoffen und Arzneizubereitungen, 1. Aufl., Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, S. 140
Berndt SF, Schulz HU (1974) J Neural Transm Suppl 11: 187–193
Fleckenstein A, Gruen G, Byon KY (1972) Inhibition of uterine contractility by the Ca+ +-antagonistic inhibitors of electromechanical coupling. Experiments on rat myometrium. In: Jung H (Hrsg.) Method Pharmacol Geburtserleichterung Uterus-Relaxation, Int Symp 1970, Thieme, Stuttgart, S. 107–116
von lssekutz B, Leinzinger M, Dirner Z (1932) Arch Exp Pathol Pharmacol 164: 158–172
Issekutz B v, Nyary A, Botz E (1932) Arch Exp Pathol Pharmacol 164: 173–187
Oswald WJ, Baeder DH (1975) South Med J 68:1. 481–1. 484
Lacroix P, Linee P, Quiniou P, Polles JP (1976) Arch Int Pharmacodyn Ther 221: 163–176
Lacroix P, Linee P, Le-Polles JB (1977) CR Soc Biol Paris 171: 214–217
Lacroix P, Linee P, Le-Polles JB (1977) CR Soc Biol Paris 171:1. 075–1. 080
Servin AL, Christinaki H, Viel C (1988) Eur J Pharmacol 149: 371–376
Berndt SF, Schulz HU, Stock K (1976) Naunyn- Schmiedeberg’s Arch Pharmacol 294: 271–275
Greenslade FC, Scott CK, Newquist KL, Krider KM, Chasin M (1982) J Pharm Sci 71: 94–100
Wuppermann D, Zimmermann F, Friedrich L (1978) Arzneim Forsch 28: 794–798
Fleckenstein A, Gruen G, Doering HJ, Haastert HP, Tritthart H (1973) Med Welt 24: 439–447
Meyer MC, Raghow G, Straughn AB (1983) Biopharm Drug Dispos 4: 401–404
Brodie RR, Chasseaud LF, Walmsley LM, Soegtrop HH, Darragh AA, O’Kelly DA (1980) J Chromatogr 182: 379–386
Renier E, Kjeldsen K, Pays M (1979) Feuill Biol 106: 111–115
Maier-Lenz H, Ringwelski L, Windorfer A (1981) Arzneim Forsch 31: 105–109
Orfanos CE, Runne U (1975) J Cutan Pathol 2: 232–239
Runne U, Orfanos CE (1975) Arch Dermatol Res 254: 55–66
Trainor FS, Phillips RE, Michie DD, Zellner SR, Hogan L jr, Chubb JM (1986) Angiology 37: 343–351
Oswald WJ, Baeder DH (1975) South Med J 68:1. 481–1. 484
Markwardt F (1972) Acta Univ Carol Med Monogr 52: 79–82
Needleman P, Corr PB, Johnson EM (1985) Drugs used for the treatment of angina: organic nitrates, calcium channal blockers, and ß-adrenergic antagonists. In: Gilman AG, Goodman LS, Rall TW, Murad F (Hrsg.) Goodman and Gilman’s The pharmacological basis of therapeutics, 7. Aufl., MacMillan, New York, S. 823
Weijlard J, Swanzey EF, Tashjian E (1949) J Am Chem Soc 71: 1889–1890
De Smet M, Peeters L, Buydens L, Massart DL (1988) J Chromatogr 457: 25–42
Surmann P (1987) Quantitative Analyse von Arzneistoffen und Arzneizubereitungen, 1. Aufl., Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, S. 140
Müller RK (1976) Die toxikologisch-chemische Analyse, Verlag Chemie, Weinheim, S. 438
Rücker G, Natarajan PN (1967) Arch Pharm 300: 276–281
Fekety KB, Medwick T (1983) J Pharm Sci 72: 1358–1360
McLamore WM, P’An SY, Bavley A (1955) J Org Chem 20: 109–117
Linturi-Laurila MK (1964) Acta Chem Scand 18: 415–420
Kazayak L, Knoblock EC (1965) Anal Chem 35: 1448–1452
Kochhar MM, Needham LL (1976) J Chromatogr 118: 418–424
Kurbjuweit HG, Kroneberg G, Spingler H (1986) Arzneim Forsch 10: 820–824
Langner A, Hagen V, Labes D, Krause E (1982) Agents Actions Suppl 10: 35–45
Legheand J, Boiron J, Cier A (1977) Ann Pharm Fr 35: 387–398
Wagner-Jauregg T, Jahn U, Büch O (1962) Arzneim Forsch 12:1. 160–1. 162
Menke G, Schuster O, Peskar BA, Loew D (1992) Eur J Pain 13: 52–58
Momma K, Hagiwara H, Konishi T (1984) Prostaglandins 28: 527–536
Davison C, Wangler J, Smith PK (1962) J Pharmacol Exper Ther 136: 226–231
Jaeger H, Gielsdorf W, Rasper J, Settlage J (1983) Dtsch Apoth Ztg 123: 365–370
Davison C, Smith PK (1961) J Pharmacol Exp Ther 133: 161–170
Ducco F, De Vercelli S, Strobbia R (1955) Gazz Med Ital 114: 93–99
Ducco F, De Vercelli S, Strobbia R (1957) Gazz Med Ital 116: 131–137
Lin JH, Hayashi M, Awazu S, Hanano M (1978) J Pharmacokin Biopharm 6: 327–337
Solling P (1948) Ugeskr Laeger 110:1. 473–1. 476
Ammitzboll F (1949) Norrdisk Med 41: 376–377
Higaki S, Hasegawa Y, Morohashi M (1989) Acta Dermatol — Kyoto 84: 15–17
Bernades P, Bonfils S, Lasserre O (1970) Thérapie (Paris) 25: 715–721
Brit. Pat. 772.721 (1957), zit. nach CA (1958) 52: 1223d
Keil W, Muschaweck R, Rademacher E (1954) Arzneim Forsch 4: 477–479
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 596
Walash MI, Rizk MS, El-Brashy A (1985) J Assoc Off Anal Chem 68,6:1209, zit. nach CA (1986) 104: 75158g
Belal F (1991) J Assoc Off Anal Chem 74(4):592–595, zit. nach CA (1991) 115:120189h
Kleber JW, Bechtol LD, Brunson MK, Chernish SM (1977) J Pharm Sci 66: 992–994
Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308: 413–427
Perrigo BJ, Peel HW, Ballantyne DJ (1985) J Chromatogr 341 (l): 81–88
Covington TR, DiPalma JR, Hussar DA, Lasagna L, Tatro DS, Whitsett TL (1988) Drug facts and comparisons. In: Kastrup EK, Olin BR, Connel SI (Hrsg.) Lippincott, St. Louis, S. 1. 098
Fotherby K (1982) Meth Find Exp Clin Pharmacol 4: 133–141
Zeelen FJ (1990) Medicinal chemistry of steroids, Elsevier, Amsterdam Oxford New York Tokyo, S. 74
Goldzieher JW (1990) Am J Obstet Gynecol 163: 318–322
Fachinformation Deposiston der Fa. Jenapharm (1990)
Mar 29, S. 1386
Toy JL, Davies JA, Hancock KW (1978) Br J Obstet Gynecol 85: 359–362
Davies T, McNicol GP, Fieldhouse G, Gallagher JC, Nordin BEC (1975) Front Hormone Res 3: 185–198
Davies T, Fieldhouse G, McNicol GP (1976) Thrombos Haemostas 35: 403–413
Lauritzen C (1974) Med Welt 25: 919–920
Liehr JG (1990) Mutat Res 238: 269–276
Madsen MT, Park CH, Thakur ML (1988) J Nucl Med 29 (6): 1038–1044
Yoo HS, Park CH, Suh JH, Madsen MT, Kim DI, Kim BS, Lee JT (1989) Cancer Chemother Pharmacol 23 Suppl:S54–58
Moffat AC (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Drugs, London
Allan GW, Lees AW, Roberts GBS (1961) Brit J Dis Chest 55: 91–95
Eule H, Werner E (1967) Beitr Klin Tuberk 134: 247–258
Lefford MJ (1969) Tubercle 50: 7–13
Tsukamura M, Tsukamura S, Mizuno S, Nakano E (1964) Am Rev Resp Dis 89: 933–935
Greenberg L, Eidus L (1962) Br J Dis Chest 56: 124–130
Eule H, Werner E (1961) Tuberkulosearzt 15: 806–812
Onuki M, Nodera O, Katori S, Saito T, Suda Y, Miyoshi J, Hujimori T (1961) Jap J Chest Dis 20: 881–885
Hughes IE, Smith H, Kane P (1962) Lancet 1: 616–617
Tacquet A, Macquat V (1961) Rev Tuberc (Paris) 25:1. 386–1. 404
Schütz I (1961) Dtsch Med Wochenschr 20: 133–139
Bickhardt R, Tuczek H (1961) Tuberkulosearzt 15: 27–32
Fox W, Robinson DK, Tall R, Mitchison DA, Kent PW, Macfadyen DM (1969) Tubercle 50: 125–143
Narang RK (1972) Tubercle 53: 137–138
Brouet G, Marche J, Chevalier J, Nicolle MH, Névot P (1961) Rev Tuberc (Paris) 25: 145–190
Leggat PO (1962) Tubercle 43: 95–96
Lees AW (1963) Brit J Dis Chest 57: 158–161
Schless JM, Allison RF, Inglis RM, White EF, Topperman S (1965) Am Rev Resp Dis 91: 728–737
Kaiich R, Eckert H (1971) Z Erkr Atmungsorg 135: 195
Swash M, Roberts AH, Murnaghan DJ (1972) Tubercle 53: 132–136
Lauritzen C, Lehmann WD (1969) Besonderheiten der Wirkungen der einzelnen Gestagene auf Morphologie und Funktion des Genitaltraktes. In: Junkmann K (Hrsg.) Die Gestagene, Kap. IX, Handbuch der Experimentellen Pharmakologie, Bd. XXII/2, Springer, Berlin Heidelberg New York, S. 1–49
Mar 28, S.1412
Langecker H (1968) Resorption, Verteilung und Ausscheidung der Gestagene. In: Junkmann K (Hrsg.) Die Gestagene, Kap. III, Handbuch der Experimentellen Pharmakologie, Bd. XXII/1, Springer, Berlin Heidelberg New York, S. 282
Zeelen FJ (1990) Medicinal Chemistry of Steroids, Elsevier, Amsterdam Oxford New York Tokyo, S. 105
Burge ES (1948) Quart Bull Northw Univ Med Sch 22: 207–212
Niederl Pat 6 406 786 (1965), zit. nach CA (1965) 63:16267e
Franz Pat (1964) 1 377 262, zit. nach CA (1965) 62:9021d
Knabe J, Koch W (1972) Arch Pharm 305: 757–765
Knabe J, Plisch J (1973) Tetrahedron Lett 10: 745–746
Dibbern HW (Hrsg.) (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf, S. 1528
Nuhn P, Woitkowitz P (1975) Pharmazie 30: 612–613
Nuhn P, Woitkowitz P (1978) Pharmazie 33: 202–205
Sasa M, Ujihara H, Ishihara K, Ohmo Y, Fujita Y, Yoshimura M, Nakamura J, Serikawa T, Yamada J, Takaori S (1989) Shinkei Kenkyu No Shinpo 33: 909–918
Coulter DA, Huguenard JR, Prince DA (1989) Neurosci Lett 98: 74–78
Pellegrini A, Curro Dossi R, Dal Pos F, Ermani M, Zanotto L, Testa G (1989) Brain Res 497: 344–360
Ferrendelli JA, Holland KD, McKeon AC, Covey DF (1989) Epilepsia 30: 617–622
Shouse MN, Stroh PJ, Vreeken T (1989) Epilepsia 30: 7–16
Buchanan RA, Fernandez L, Kinkel AW (1969) Clin Pharmacol Ther 9: 393–398
Buchanan RA, Kinkel AW, Smith TC (1973) Int J Clin Pharmacol 7: 213–218
Chang T, Dill WA, Glazko AJ (1972) Ethosuximide: Absorption distribution, and excretion. In: Woodbury DM, Penry JK, Schmidt RP (Hrsg.) Antiepileptic drugs, Raven Press, New York, S. 417–423
Koup JR, Rose JQ, Cohen ME (1978) Epilepsia 19: 535–539
Horning MG, Stratton C, Nowlin J, Harvey DJ, Hill RM (1973) Drug Metab Dispos 1: 535–539
Sherwin AL (1978) Clinical pharmacology of ethosuximide. In: Pippenger CE, Penry JK, Kutt H (Hrsg.) Antiepileptic drugs: Quantitative analysis and interpretation, Raven Press, New York, S. 292
Baselt RC (1978) Disposition of toxic drugs and chemicals in man, Conn Biomedical Publication, Canton, S. 73–75
Troupin AS (1984) Ann Int Med 100: 854–858
Buchanan RA, Kinkel AW, Turner JL, Heffelfinger JC (1976) Clin Pharmacol Ther 19: 143–147
Weber E (1988) Taschenbuch der unerwünschten Arzneiwirkungen, Fischer, Stuttgart, S. 216–217
Buchanan RA (1972) Ethosuximide: Toxicity. In: Woodbury DM, Penry JK, Schmidt RP (Hrsg.) Antiepileptic drugs, Raven Press, New York, S. 449–454
Goldensohn ES, Hardie J, Borea ED (1962) JAMA 180: 840–842
Stoehr GP, Sherwin AL (1981) Ethosuximide. Therapeutic use and serum concentration monitoring. In: Taylor WJ, Finn AL (Hrsg.) Individualizing drug therapy, practical applications of drug monitoring, Gross Townsend Frank, New York, S. 28–48
Eadie MJ (1984) Drugs 27: 328–363
Nakanishi H, Fujii T (1990) Pharmacol Biochem Behav 36: 163–168
Covington TR, Di Palma JR, Hussar DA, Lasagna L, Tatro DS, Whitsett TL (1988) Drug facts and comparisons. In: Kastrup EK, Olin BR, Connel SI (Hrsg.) Lippincott, St. Louis, S. 1. 149–1. 150
Windorfer A jr, Saurer W (1977) Neuropaediat 8: 29–41
Richens A, Houghton GW (1975) Effect of drug therapy on the metabolism of phenytoin. In: Schneider H, Janz D, Gardner-Thorpe C, Meinardi H, Sherwin AL (Hrsg.) Clinical pharmacology of antiepileptic drugs, Springer, Berlin, S. 87–95
Reinken L (1973) Clin Chim Acta 48: 435–436
Ellenhorn MJ, Barceloux DG (1988) Medical Toxicology. Diagnosis and treatment of human poisoning, Elsevier, New York Amsterdam London, S. 254–257
Pinner A (1888) Chem Ber 21: 2325
Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, London
Larsen NE, Naestoft J (1974) J Chromatogr 92: 157
Rall TW, Schleifer LS (1990) Drugs effective in the therapy of the epilepsies. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s The pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S. 436–462
Meyer MC, Holcombe BJ, Burckart GJ, Raghow G, Yau MK (1983) Clin Pharmacol Ther 33: 329–340
Miyamoto K, Seino M, Ikeda Y (1975) Consecutive determination of the levels of twelve antiepileptic drugs in blood and cerebrospinal fluid. In: Schneider H, Janz D, Gardner Thorpe C, Meinardi H, Sherwin AL (Hrsg.) Clinical pharmacology of anti-epileptic drugs, Springer, Berlin, S. 323–330
Bius DL, Yonekawa WD, Kupferberg HJ, Cantor F, Dudley KH (1980) Drug Metab Dispos 8: 223–229
Sjo O, Hvidberg EF, Larsen NE, Naestoft J (1975) Clin Exp Pharmacol Physiol 2: 185–192
Naestoft J, Hvidberg EF, Sjo O (1976) Clin Exp Pharmacol Physiol 3: 453–459
Carter CA, Helms RA, Boehm R (1984) Neurology 34: 791–795
Korberly BH, Mrazik TJ, Graziani LJ (1981) Am J Dis Child 135:1.139–1.140
Biton V, Gates JR, Ritter FJ, Loewenson RB (1990) Epilepsia 31: 433–437
Browne TR, Szabo GK (1989) J Clin Pharmacol 29: 270–271
Covington TR, DiPalma JR, Hussar DA, Lasagna L, Tatro DS, Whitsett TL (1988) Drug facts and comparisons. In: Kastrup EK, Olin BR, Connell SI (Hrsg.) Lippincott, St. Louis, S. 1. 148
Zablen M, Brand N (1977) N Engl J Med 297: 1. 404
Reynolds MC jr, Miska RM (1981) Neurology 31: 480–484
Maren TH, Parcell AL, Malik MN (1960) J Pharm Exp Ther 130: 389–400
Maren TH (1969) Renal carbonic anhydrase and sulfonamide inhibitors. In: Eichler O, Farah A, Herken H, Welch AD (Hrsg.) Diuretica, Handb Exp Pharm, Springer, Berlin Heidelberg New York, 24: 193–256
Moyer JH, Ford RV (1958) Am J Cardiol 1: 497–504
Mar 29, S. 1.428
Wirth W, Gloxhuber C (1981) Toxikologie, Thieme, Stuttgart, S. 198
Indruch M, Gabriel J, Dostal M, Mayer J (1982) PI CS 195368, zit. nach CA 97(15):127503z
Lau-Cam CA (1978) J Chromatogr 151: 391–395
Moore E, Lau-Cam CA (1986) J Assoc Off Anal Chem 69:629–632, zit. nach CA 105(12):102715r
Deckert FW (1972) J Chromatogr 64: 355–357
Moffat AC (1986) Clark’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London
Suttie JW (1987) Adv Exp Med Biol 214: 3–16
Preusch PC, Smalley DM (1990) Free Radic Res Commun 8: 412–415
Myszka DG, Swenson RP (1991) J Biol Chem 266:4. 789–4. 797
Liska DJ, Suttie JW (1988) Biochemistry 27:8. 636–8. 641
Mar 29, S.339
Arman M, Jamali F (1983) J Chromatogr 272: 406–410
Patent Japan 12,418 (67) (C1.16D417) July 14, Appl. Dec. 12, 1963, zit. nach CA (1968) 68: 59372e
Menard M, Mitchell L, Komlossy J, Wrigley A, Chubb FL (1961) Can J Chem 39: 729–734
Handbook of Pharmaceutical Excipients (1986), American Pharmaceutical Association, Washington, USA, S. 116–117
Kurz H (1989) Antitussiva und Expektoranzien, Wiss Verl Ges, Stuttgart, S. 90
Eichholtz F (1942) Lehrbuch der Pharmakologie, Springer-Verlag, Berlin, S. 195
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Suter CM, Ruddy AW (1944) J Am Chem Soc 66: 747
Moffat AC (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 605
Stead AH, Gill R, Wright T, Gibbs JP, Moffat AC (1982) Analyst 107: 1106–1168
Clarke EGC (1969) Isolation and Identification of Drugs, l.Aufl., The Pharmaceutical Press, London, S. 340–341
Sutter CM, Ruddy AW (1944) J Am Chem Soc 66: 747
Moffat AC (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 605
Leffler EB, Spencer HM, Burger A (1951) J Am Chem Soc 73: 2611–2613
The Givaudan Index (Specifications of Synth, and Isolates for Perfumery) (1961) 2. Aufl., S. 154
Prosser HJ, Groffman DM, Wilson AD (1982) J Dent Res 61:1. 431–1. 435
Fischer FJ (1977) Brit Dent J 143: 231–235
Adams HJ, Kronberg GH,Takman BH (1972) Ger. Offen. 2, 162,744, zit. nach CA (1972) 77: 101244c
Astra AB Jpn. Kokai Tokkyo Koho 79,112,821 /Swed. Appl. 78/1,062
Gennaro AR (Hrsg.) (1985) Remington’s Pharmaceutical Sciences Mack Publishing Company, Easton, Pennsylvania
Covino BG (1986) Br J Anaesth 58: 701–716
Estler CJ (1986) Med Monatsschr Pharm 9: 197–210
Lynch C (1986) Anesth Analg 65: 551–559
Covino BG (1987) Toxicity and systemic effects of local anesthetic agents. In: Strichartz GR (Hrsg.) Handbuch der experimentellen Pharmakologie, Bd. 81: Local Anesthetics, Springer-Verlag, Berlin Heidelberg, S. 187–212
Hartung HJ, Osswald PM, Abel J, Meissner R (1980) Anästh Intensivther Notfallmed 15: 392–395
Tucker GT (1986) Br J Anaesth 58: 717–731
Strasser K, Abel J, Breulmann M, Schumacher I, Siepmann HP, Trampisch HJ (1981) Anaesthesist 30: 14–18
Burm AG (1989) Clin Pharmacokin 16: 283–311
Hempel V, Lenz G (1982) Anästh Intensivmed 23: 337–345
Nau H (1985) Dev Pharmacol Ther 8: 149–181
Arthur GR (1987) Pharmacokinetics of local anesthetics. In: Strichartz GR (Hrsg.) Handbuch der experimentellen Pharmakologie, Bd. 81, Local Anesthetics, Springer-Verlag, Berlin Heidelberg, S. 165–185
Tucker GT, Mather LE (1975) Br J Anaesth 47: 213–224
Vine J, Morgan D, Thomas D (1978) Xenobiotica 8: 509–513
Scott DB, McClure JH, Giasi RM, Seo J, Covino BG (1980) Br J Anaesth 52:1. 033–1. 037
Sinclair CJ, Scott DB (1984) Br J Anaesth 56: 147–153
Axelsson K, Nydahl PA, Philipson L, Larsson P (1989) Anesth Analg 69: 739–747
Giovannitti JA, Bennett CR (1983) J Am Dent Assoc 107: 616–618
Hlava GL, Reinhardt RA, Kalkwarf KL (1984) J Periodontol 55: 364–367
Smith PH, Smith ER (1983) Ophthalmic Surg 14: 569–574
Block A, Covino BG (1982) Reg Anesth 6: 55–61
Blaser B, Worms KH, Germschei HG, Wollmann K (1971) Z Anorg Allg Chem 381: 247–259
Kasparek F (1968) Monatsh Chem 99: 2016–2023
Bikhman BI, Urinovich EM, Kireeva AY, Shugal NF, Dyatlova NM (1973) Russ J Inorg Chem (engl. Übersetzung) 18: 1273–1275
Harris RK, Merwin LH, Hägele G (1989) J Chem Soc Faraday Trans 1 85: 1409–1423
Collins AJ, Perkins PG (1977) J Appl Chem Biotechnol 27:651–661, zit. nach CA (1978) 88:170231k
Daley-Yates PT, Gifford LA, Hoggarth CR (1989) J Chromatogr 490: 329–338
Lai H, Zhao F, Du H (1988) Huaxue Shijie 29:69–72, zit. nach CA (1988) 109: 221636h
Jap Pat 62.258.697 (1988), zit. nach CA (1989) 110:P236940x
Eur Pat 284.082 (1988), zit. nach CA (1989) 110:104837j
Francis MD (1969) Calcif Tissue Res 3: 151–162
Fleisch H, Russel RGG, Bisaz S, Mühlbauer RC, Williams DA (1970) Eur J Clin Invest 1: 12–18
Hansen NM jr, Felix R, Bisaz S, Fleisch H (1976) Biochim Biophys Acta 451: 549–559
Jung A, Bisaz S, Fleisch H (1973) Calcif Tissue Res 11: 269–280
Fleisch H, Maerki J, Russel RGG (1966) Proc Soc Exp Biol Med 122: 317–320
Fleisch H, Russel RGG, Francis MD (1969) Science 165:1. 262–1. 264
Russel RGG, Mühlbauer RC, Bisaz S, Williams DA, Fleisch H (1970) Calcif Tissue Res 6: 183–196
Rosenblum IY, Flora L, Eisenstein R (1975) Atherosclerosis 22: 411
Rosenblum IY, Black HE, Ferrell JF (1977) Calcif Tissue Res 23: 151–159
Plasmans CMT, Kuypers W, Slooff TJJH (1978) Clin Orthop Rel Res 132: 233–243
Fraser D, Russel RGG, Pohler C, Robertson WG, Fleisch H (1972) Clin Sci 42: 197–207
Briner WW, Francis MD, Widder JS (1971) Int Dent J 21: 61–73
King WR, Francis MD, Michael WR (1971) Clin Orthop 78: 251–270
Schenk R, Merz WA, Mühlbauer R, Russel RGG, Fleisch H (1973) Calcif Tissue Res 11: 196–214
Larsson A (1974) Calcif Tissue Res 16: 109–127
Mühlbauer RC, Russel RGG, Williams DA, Fleisch H (1971) Eur J Clin Invest 1: 336–344
Jee WSS, Black HE, Gotcher JE (1981) Clin Orthop Rel Res 156: 39–51
Hähnel H, Mühlbach R, Lindenhayn K, Schaetz P, Schmidt UJ (1973) Z Alternsforsch 27: 289–292
Martodam RR, Thornton KS, Sica DA, Souza SM, Flora L, Mundy GR (1983) Calcif Tissue Int 35: 512–519
Jung A, Bornand J, Mermillod B, Edouard C, Meunier PJ (1984) Cancer Res 44:3. 007–3. 011
Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P (1983) Calcif Tissue Int 35: 87–99
Fast DK, Felix R, Dowse C, Neumann WF, Fleisch H (1978) Biochem J 172: 97–107
Chambers TJ (1980) J Pathol 132: 255–262
Felix R, Bettex JD, Fleisch H (1981) Calcif Tissue Int 33: 549–552
Cecchini M, Felix R, Cooper PH, Fleisch H (1984) Effect of bisphosphonates on bone marrow macrophages. XVIII Europ Symp on Calcified Tissues, Angers Oct 15–18 abstract
Recker RR, Saville PD (1973) Toxicol Appl Pharmacol 24: 580–589
Fleisch H (1985) Ther Umschau 42: 366–375
Michael WR, King WR, Wakim JM (1972) Toxicol Appl Pharmacol 21: 503–515
Smith R, Russel RGG, Bishop M (1971) Lancet I: 945–947
Russel RGG, Smith R, Preston C, Walton RJ, Woods CG (1974) Lancet I: 894–898
Guncaga J, Lauffenburger R, Lentner C, Dambacher MA, Haas HG, Fleisch H, Olah AJ (1974) Horm Metab Res 6: 62–69
De Vries HR, Bijvoet OLM (1974) Neth J Med 17: 281–298
Altman RD, Johnston CC, Khairi MRA, Wellmann H, Serafini AN, Sanley RR (1973) New Engl J Med 289:1. 379–1. 384
Canfield R, Rosner W, Skinner J, McWorther J, Resnick L, Feldman F, Kammerman S, Ryan K, Kunigonis M, Bohne W (1977) J Clin Endocrinol Metab 44: 96–106
Kantrowitz FG, Byrne MH, Schiller AL, Krane SM (1975) Arthritis Rheum 18: 407
Siris ES, Canfield RE, Jacobs TP, Baquiran DC (1980) Arthritis Rheum 23:1. 177–1. 184
Sturzenberger OP, Swancar JR, Reiter G (1971) J Periodontal 42: 416
Mühlemann HR, Bowles D, Schau A, Bernimoulin JP (1970) Helvetica Odont Acta 14: 31–33
Watts NB (1990) New Engl J Med 323: 73–79
Bounameaux HM, Schifferli J, Montani JP, Jung A, Chatelanat F (1983) Lancet I: 471
Recker RR, Hassing GS, Lau JR, Saville PD (1973) J Lab Clin Med 81: 258–266
Czech CS 223.270, zit. nach CA (1987) 106:67494q
Afonin EG, Pechurova NJ (1987) J Gen Chem USSR (engl, transl.) 57 (3): 469–474
Liggett SJ, Libby RA (1970) Talanta 17 (II): 1135–1140
Ismail Z, Aldous S, Triggs EJ, Smithurst BA, Barry HD (1987) J Chromatogr 404(2) :372–377
Jap.Kokai Tokkyo Koho JP 6200.418, zit. nach CA (1987) 106:162433c
Diehl FL (1964) US Pat 3.159.581, zit. nach CA (1965) 62: 4225G
Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308: 413
Lücke L, Jassmann E (1968) Ger. (East) 63,372, zit. nach CA (1969) 70: 77560k
Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, 2. Aufl., Bd. 1, S. 602, Noyes Publications, Park Ridge, New Jersey USA
Kametani T, Kaneda S, Noguchi l, Nakai K, Seito K (1969) Yakugaku Zasshi 89:1613, zit. nach CA (1970) 72: 54913e
Kametani T, Noguchi l (1968) Yakugaku Zasshi 88:914, zit. nach CA (1969) 70: 46975v
Blank B, Zuccarello WA, Cohen SR, Frishmuth GJ, Scaricaciottoli D (1969) J Med Chem 12: 271
Kuhnert-Brandstätter M, Kofler A, Vlachopoulos A, Lobenwein A (1970) Sci Pharm 38: 154
Kleemann A, Engel J, Pharmazeutische Wirkstoffe, Synthese, Patente, Anwendungen, 2. Aufl. (1982), Thieme Stuttgart
Roth H J, Eger K, Troschütz R, Pharmazeutische Chemie II — Arzneistoffanalyse, 3. Aufl. (1990), Thieme Stuttgart
Dibbern H W (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf
Mitteilungen der Firma Boehringer Ingelheim
Limbourg P, Just H, Lang KF (1974) Z Kardiol 63: 530–541
Coleman AJ, Leary WP, Asmal AC (1975) Eur J Clin Pharmacol 8: 41–45
Sollberg G (1975) Med Welt 26: 399–402
Hiraoka T, Serizawa J (1974) Chem Pharm Bull Tokyo 22: 500–504
Hengstmann JH, Weyand U, Dengler HJ (1975) Eur J Clin Pharmacol 9: 179–187
Donike M, Dell HD, Kamp R (1978) Arzneim Forsch 28: 856–860
Hengstmann JH, Hengstmann R, Schwonzen S, Dengler HJ (1982) Eur J Clin Pharmacol 22: 463–467
Haustein KO, Hüller G (1985) Pharmazie 40: 776–778
Anderhus J, Hansen E (1969) Curr Ther Res 11: 338–343
Miller E, Wiener L, Bloomfield D (1973) Arch Neurol 29: 99–103
Garbe WE, Clasen J (1978) Med Welt 29: 939–942
Kaden F, Maurer W, Sachomig A, Spohr U (1978) Dtsch Med Wochenschr 103:1. 513–1. 517
Polzien P, Bracharz H, (1980) Med Klin 75: 878–882
Gemeinhardt S, Schardt F, Polzien P (1981) Dtsch Med Wochenschr 106:1. 095–1. 099
Hengstmann JH, Brecht T, Ewers W (1986) Arzneim Forsch 36: 874–877
Cruz A, Buhling M, Seibel K (1985) Arzneim Forsch 35:1. 086–1. 089
Retief LW, Roelofse JA, Meyer BH (1984) S Afr Med J 66: 526–528
Müller H, Brahler A, Borner U, Boldt J, Stoyanov M, Hempelmann G (1985) Reg Anästh 8: 43–49
DE 1493567 (1965) Concordant mit NE 6614150, zit. nach CA (1967) 67: 91112
DD 57130 (1966), zit. nach CA (1968) 69:43637
Dibbern H (Hrsg.) (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Edition Cantor Aulendorf, S. 1804
Hansch C, Sammes PG, Taylor JB (Hrsg.) (1990) Comprehensive Medicinal Chemistry, Pergamon Press Oxford, Bd. 6, S. 505
Beckmann R (1979) Arzneim Forsch 29: 499–502
DE 1493533 (1964) Concordant mit NE 6503266, zit. nach CA (1966) 64: 9819
US 4110470 (1978), zit. nach CA (1979) 90:138204
Schütz H, Pielmeyer A, Weller G (1990) Ärztl Lab 36: 113–123
Dufait R (1983) Vet Med Small Animal Clin 78:1. 055–1. 057
Stampehl GC (1982) Inaugural-Dissertation, TiHo Hannover
Gründer HD (1980) Dermatomycoses of cattle and their chemotherapy. Trends in veterinary pharmacology and toxicology, Proc of the first Eur Congress, Zeist, S. 275–284
Wilkinson GT (1979) J Small Animal Practice 20: 111–115
Brandes R (1970) Inaugural-Dissertation, TiHo Hannover
Van Soeren JH, van Miert ASJPAM, van Gogh H (1979) Pharm Weekbl 114: 463–474
El-Sherif MMT, Shawkat E, Fayed AA (1981) Vet Med Rev 2: 186–189
Kunstyr I, Heimann W, Matthiesen T, Militzer K (1980) Berl Muench Tieraerztl Wochenschr 93:347– 350
Estler CJ (1990) Lehrbuch der allgemeinen und systematischen Pharmakologie und Toxikologie, Schattauer, Stuttgart New York, S. 513
Nicht publizierte Unterlagen
Pilger C, Nethercott JR, Weksberg F (1986) Contact Dermatitis 14 (4): 201–204
Vanhee J, Ceuterick A, Dooms M, Dooms-Goossens A (1980) Contact Dermatitis 6 (6): 443
Malten KE (1978) Contact Dermatitis 4 (5): 296–299
Cozzi P, Menchetti P, De Carneri I, Trane F (1991), zit. nach CA 91(9):74331j
De Carneri I, Ambrosini A, Barbiera P, Beltrame D, Buttinoni A, Guidi P, Meinardi G, Trane F (1972) II Farmaco Ed Prat 27: 585–598
Singh PP, Srivastava VB, Talwalker S (1987) Indian J Parasitol 11: 15–20
De Carneri I, Candia Carnervali MD, Trane F, Meinardi G (1976) G Mal Infett Parassit 28: 229–240
Huggins DW (1976) Tratamento de amebiase intestinal cronica com etofamida. Resumes de trabajos libres Congreso (IV) Latinoamericano de Parasitología, San Jose, Costa Rica, 7.–11. Dec. 1976, S. 135
Huggins DW (1976) Ensaio clinico e quimioprofilactico com etofamida, una substancia amebicida numacomunidade aberta. Resumes de trabajos libres Congreso (IV) Latinoamericano de Parasitologica, San Jose, Costa Rica, 7.–11. Dec. 1976, S. 135
Boltze KH, Kreisfeld H (1977) Arzneim Forsch 27:1. 300–1. 312
Dell HD, Fiedler J, Wäsche B (1977) Arzneim Forsch 27:1. 312–1. 316
Dell HD, Kamp R (1970) Arch Pharm 303:785–791 [s. auch Dell HD, Doersing M, Fischer W, Fiedler J, Jacobi H, Kamp R (1981) Arzneim Forsch 31:9–16]
Vane JR (1971) Nature (New Biol) 231: 232–235
Vane JR (1987) Drugs 33 (Suppl I): 18–27
Fruchtmann R, Krupka U, Pelster B (1984) Akt Rheumatol 9: 165–168
Nakamura H, Motoyoshi S, Ishii K, Seto Y, Shimoda A, Kadokawa T (1987) Nippon Yakurigaku Zasshi 89: 15–24
APr
Nakamura H, Motoyoshi S, Imazu C, Ishii K, Yokoyama Y, Seto Y, Kadokawa T, Shimizu M (1982) Nippon Yakurigaku Zasshi 80: 125–135
Nakamura H, Yokoyama Y, Motoyoshi S, Seto Y, Ishii K, Imazu C, Kadokawa T, Shimizu M (1982) Nippon Yakurigaku Zasshi 80: 183–194
Heindl I, Lorenz D, Sieberns S, Blumberger W (1977) Arzneim Forsch 27: 1357–1363
Gross W (1983) Fortschr Med 101: 1995–1998
Rechziegler H (1986) Therapiewoche 36: 4674–4683
Pelster B, Dell HD (1990) Arzneim Forsch 40: 297–300
Stratz T (1990) Fortschr Med 108: 264–266
Beckermann B, Bock E, Kamp R, Dell HD (1990) Arzneim Forsch 40: 305–311
Dell HD, Brons J, Fiedler J, Kamp R, Pelster B (1990) Arzneim Forsch 40: 300–305
Dell HD, Fiedler J, Jacobi H, Wäsche B (1977) Arzneim Forsch 27: 1322–1325
Dell HD, Doersing M, Fischer W, Fiedler J, Jacobi H, Kamp R (1981) Arzneim Forsch 31: 9–16
Dell HD, Beckermann B, Fiedler J, Kamp R (1990) Arzneim Forsch 40: 311–316
Tepe HJ, Blumberger W (1978) Med Welt 29: 448–451
Degenhardt A, Zick C, Hausen BM (1988) Z Hautkr 63: 475–478
Knoll R, Ulrich R, Spallek W (1990) Sportverletz Sportschaden 4: 96–98
Dell HD, Fiedler J (1983) Arch Pharm 316: 746–751
DE 1941217 (1971), zit. nach CA (1971) 74:125446
DE 2542413 (1976), zit. nach CA (1977) 86:106404
DE 2304405 (1973), zit. nach CA (1974) 80:3394
Kummer M, Schatton W, Linde H, Oelschläger H (1979) Pharm Ztg 124: 1312–1317
Dibbern HW (Hrsg.) (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf, 1807
Mitteilung der Fa. Merz (Frankfurt/M.)
In: Hansch C, Sammes PG, Taylor JB (Hrsg.) (1990) Comprehensive Medicinal Chemistry, Pergamon Press Oxford, Bd. 6, S. 507
Heinisch G, Matous H, Rank W, Wunderlich R (1981) Sci Pharm 49: 472–482
Oelschläger H, Rothley D, Ewert M, Nachev P (1980) Arzneim Forsch 30: 984–988
Altmayer P, Garrett ER (1983) J Pharm Sci 72: 1309–1318
Kaffarnik H, Schneider J, Schubotz R, Zöfel P, Hausmann L, Goebel KM (1980) Artery 8: 537–546
Paoletti R, Fanceshini G, Sirtori CR (1983) Am J Cardiol 52: 21B–27B
Catalan RE, Aragones MD, Martinez AM, Armijo M, Priego JG (1979) Gen Pharmacol 10: 455–458
Priego JG, Maroto ML, Pina M, Catalan RE (1979) Gen Pharmacol 10: 215–219
Söttl F, Grabo F (1979) Therapiewoche 29: 614–619
Haberbosch W, Gnasso A, Poli A, Augustin J (1983) Therapiewoche 33: 78–82
Wagner HA, Cremer P, Creuzfeldt C, Seidel D (1984) Eur J Clin Invest 14: 8–14
Ortega MP, Sunkel C, Armijo M, Priego JG (1980) Thromb Res 19: 409–416
Betz H, Hämmerle H (1986) Arzneim Forsch 36: 92–98
Oelschläger H, Rothley D, Ewert M, Nachev P (1980) Arzneim Forsch 30: 948–960
Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor Aulendorf
Jacobi H, Lange A, Pfleger K (1956) Arzneim Forsch 6: 41–43
Jauch R, Zimmer A (1978) Arzneim Forsch 28: 693–697
Metz G, Specker M (1980) Arzneim Forsch 30: 2014–2019
EP 59974 (1982), zit. nach CA (1983) 98:53542
Dibbern HW (Hrsg.) (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Edition Cantor, Aulendorf, S. 1808
Metz G, Specker M, Sterner W, Heisler E, Grahwit G (1977) Arzneim Forsch 27: 1173–1177
Lücker PW, Wetzelsberger K, Erking W, Donike M (1980) Arzneim Forsch 30: 2045–2053
Ritschel WA, Thompson GA, Lücker PW, Wetzelsberger K (1980) Arzneim Forsch 30: 2020–2023
Metz G, Sim AK, McCraw AP, Cleland ME (1986) Arzneim Forsch 36:1. 363–1. 365
Schneider J, Mühlfellner G, Mühlfellner O, Hausmann L, Schubotz R (1980) Arzneim Forsch 30:2. 059–2. 062
Vorberg G, Ziegler WJ (1980) Arzneim Forsch 30:2. 068–2. 072
Lücker PW, Wetzelsberger K, Erking W, Donike M (1980) Arzneim Forsch 30:2. 045–2. 053
Godefroi EF, Janssen PAJ, Van Heertum AHMT, Niemegeers CJE (1965) J Med Chem 8: 220–223
Doenieke A (1974) Acta Anaesthesiol Belg 3: 307–315
Doenieke A, Löffler B, Kugler J (1982) Br J Anaesth 54: 393–400
Schwilden H, Schüttler J, Stoeckel H (1985) Eur J Anaesth 2: 121–131
Kettler D, Sonntag H, Dontah U (1974) Anaesthesist 23: 116–121
Nimmo WS, Miller M (1983) Contemp Anesth Pract 7: 83
Schüttler J, Wilms M, Lauven PM, Stoeckel H, Koenig A (1980) Anaesthesist 29: 658–661
Hamme van MJ, Ghonheim MM, Ambre JJ (1978) Anesthesiology 49: 274–277
Dearden NM, McDowall DG (1985) Br J Anaesth 57: 361–368
Kulka PJ, Bremer F, Schüttler J (1993) Anaesthesist 42: 205–209
Wagner RL, White PF, Kan PB (1984) New Engl J Med 320: 1415–1421
Ledingham IM, Watt I (1983) Lancet I: 1270
Van Breuseghem R, van Cutsem J, Thienpont D (1967) Chemotherapia 12: 107–122
Mitteilung (18.1.91) der Firma Janssen
Keller-Juslén C, Kuhn M, v Wartburg, Stähelin H (1971) J Med Chem 14: 936–940
UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe (1978) Dibbern HW (Hrsg.) Editio Cantor Aulendorf Nr.990
Huang CC, Hou Y, Wang JJ (1973) Cancer Res 33:3. 123–3. 129
Loike JD, Horwitz SB (1976) Biochem 15:5. 435–5. 442
Loike JD, Horwitz SB (1976) Biochem 15: 5443–5448
Wozniak AJ, Ross WE (1983) Cancer Res 43: 120–124
Kalwinsky DK, Look AT, Ducore J, Fridland A (1983) Cancer Res 43:1. 592–1. 597
Liu LF, Rowe TC, Yang L, Tewey KM, Chen GL (1983) J Biol Chem 258:15. 365–15. 370
Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM, Liu LF (1984) J Biol Chem 259:13. 560–13. 566
van Maanen JMS, Retèl J, de Vries J, Pinedo HM (1988) J Nat Cancer Inst 80:1. 526–1. 533
Rao PN (1979) G2 arrest induced by anticancer drugs. In: Busch H, Crooke ST, Daskal Y (Hrsg.) Effects of drugs in the cell nucleolus, Academic Press, New York London Toronto Sydney San Francisco, S. 475
Grieder A, Maurer R, Stähelin H (1974) Cancer Res 34:1. 788–1. 793
Drewinko B, Green C, Loo TL (1976) Cancer Treat Rep 60:1. 619–1. 625
Drewinko B, Loo TL, Brown B, Gottlieb JA, Freireich EJ (1976) Cancer Biochem Biophys 1: 187–195
Arnold AM (1979) Cancer Chemother Pharmacol 3: 71–80
Barlogie B, Drewinko B (1978) Eur J Cancer 14: 741–745
Issel BF, Crooke ST (1979) Cancer Treat Rev 6: 107–124
Brunner KW, Sonntag RW, Ryssel HJ, Cavalli F (1976) Cancer Treat Rep 60:1. 377–1. 379
Lau ME, Hansen HH, Nissen NI, Pedersen H (1979) Cancer Treat Rep 63: 485–487
Smyth RD, Pfeffer M, Scalzo A, Comis RL (1985) Semin Oncol Suppl 2, 12: 48–51
Harvey VJ, Slevin ML, Joel SP, Barnett MJ, Smythe MM, Ang LM, Johnston A, Wrigley PFM (1984) Proceedings of ASCO 3:24, Abstr C90
Harvey VJ, Slevin ML, Joel SP, Johnston A, Wrigley PFM (1985) Br J Cancer 52: 363–367
Carney DN (1991) Cancer 67: 299–302
Hainsworth JD, Johnson DH, Frazier SR, Greco FA (1989) J Clin Oncol 7: 396–401
Slevin ML, Clark PJ, Joel SP, Harvey VJ (1989) J Clin Oncol 7:1. 333–1. 340
Slevin ML, Joel SP, Richards M, Harvey VJ, Whomsley R, Wrigley PFM (1986) Proceedings of ASCO 27:176, Abstr 699
Allen LM, Creaven PJ (1975) Eur J Cancer 11: 697–707
O’Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, Wittes RE (1985) N Engl J Med 312: 692–700
Creaven PJ, Allen LM (1975) Clin Pharmacol Ther 18: 221–226
Creaven PJ, Allen LM (1975) Clin Pharmacol Ther 18: 227–233
Allen LM, Marcks C, Creaven PJ (1976) Proc Amer Ass Cancer Res & Am Soc Clin Oncol 17:6, AACR Abstr 21
Rozencweig M, von Hoff DD, Henney JE, Muggia FM (1974) Cancer 40: 334–342
Jungi WF, Senn HJ (1975) Cancer Chemother Rep 59: 737–742
Schmoll HJ, Niederle N, Achterrath W (1981) Klin Wochenschr 59:1. 177–1. 188
Greco FA, Johnson DH, Hainsworth JD (1991) Cancer 67: 303–309
Radice PA, Bunn PA jr, Ihde DC (1979) Cancer Treat Rep 63:1.231–1.239
Cavalli F, Sonntag RW, Rysell HJ, Brunner KW (1979) Cancer Treat Rep 61: 1. 411
Schechter JP, Jones SE (1979) Cancer Chemoth Rep 59: 887–888
Sieber SM, Whang-Peng J, Botkin C, Knutsen T (1978) Teratology 18: 31–48
Singh B, Gupta RS (1983) Cancer Res 43: 577–584
Fontana JA (1979) Cancer Treat Rep 63: 224–225
Ullmann’s Encyclopedia of industrial chemistry (1985) Bd. A2, S. 282
Moffat AC (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London 2. Aufl., S. 608–609
Pharmaceutical Codex (1979) 11. Aufl., The Pharmaceutical Press, London S. 345
Benyhe S, Varga E, Borsodi A, Wollemann M (1990) Acta Physiol Hung 76 (4): 291–294
Delay-Goyet P, Zajac JM, Javoy-Agid F, Agid Y, Roques BP (1987) Brain Res 414 (1): 8–14
Dickenson AH, Sullivan AF, McQuay HJ (1990) Pain 42 (2): 227–234
Flecknell PA, John M, Mitchell M, Shurey C, Simpkin S (1983) Lab Anim 17 (2): 104–109
Holland MJ, Simon EJ (1984) Neuropeptides 5 (1– 3): 65–68
Jacobson ER, Chen CL, Gronwall R, Tiller A (1986) J Am Vet Med Assoc 189(9):1. 079–1. 081
Kreeger TJ, Plotka ED, Seal US (1987) J Wildl Dis 23 (4): 619–624
Leshem M, Frenk H, Coghill RC, Mayer DJ (1991) Pharmacol Biochem Behav 38 (2): 475–478
Magnan J, Lemay J, Tiberi M (1988) Brain Res 466 (2): 300–303
Rosenbaum JS, Holford NH, Sadee W (1984) Brain Res 291 (2): 317–324
Semafuko WEB, Follett DL, Dixon WR (1988) Pharmacology 37 (3): 195–202
Wiesner H, von Hegel G (1985) Tierärztl Prax 13 (1): 113–127
Satzinger G (1977) Arzneim Forsch 27:1. 742–1. 745
Scheitza E (1977) Arzneim Forsch 27: 1807–1814
Greven J, Heidenreich O (1977) Arzneim Forsch 27/II:1. 755–1. 757
Satzinger G (1977) Arzneim Forsch 27/II:1. 742–1. 745
Herrmann M, Bahrmann H, Birkenmayer E, Ganser V, Heldt W, Steinbrecher W (1977) Arzneim Forsch 27/II:1. 745–1. 754
Greven J, Heidenreich O (1978) Naunyn-Schmiedeberg’s Arch Pharmacol 304: 282–287
Greven J, Klein H, Heidenreich O (1978) Naunyn-Schmiedeberg’s Arch Pharmacol 304: 289–296
Greven J, Defrain W, Glaser K, Meywald K, Heidenreich O (1980) Pflügers Arch 384: 57–60
Heintze K, Petersen KU, Heidenreich O (1982) Naunyn-Schmiedeberg’s Arch Pharmacol 318: 363–367
Osswald H, Wang F, Sander-Osswald S, Forrest JN jr (1987) Stereospecific inhibition of active chloride secretion in the salt gland of the shark squalus acanthias by the diuretic ozolinone. In: Puschett JB, Greenberg A (Hrsg.) Diuretics II: Chemistry, Pharmacology, and Clinical Applications, Elsevier Science Publishing, New York Amsterdam London, S. 227–230
Scheitza E (1977) Arzneim Forsch 27/II:1. 807–1. 814
Knauf H, Liebig R, Schollmeyer P, Rosenthal J, Kölle EU, Mutschler E (1984) Eur J Clin Pharmacol 26: 687–693
Dorigo P, Belluco P, Coradi L, Gaion RM, Maragno I (1990) Arch Int Pharmacodyn 307: 130–141
Von Hodenberg A, Vollmer KO, Kiemisch W, Liedtke B (1977) Arzneim Forsch 27/II:1. 776–1. 785
Heidenreich O, Gharemai G, Keller P, Kook Y, Schmiz K (1964) Arzneim Forsch 14:1. 242–1. 248
Vollmer KO, von Hodenberg A, Poisson A, Gladigau V, Hengy H (1977) Arzneim Forsch 27/II:1. 767–1. 776
Gladigau V, Vollmer KO (1977) Arzneim Forsch 27/II:1. 786–1. 799
Beermann B, Grind M (1987) Clin Pharmacokin 13: 254–266
Knauf H, Missmahl M, Schölmerich J, Gerok W, Mutschler E (1987) Arzneim Forsch 37:1. 385–1. 388
Ward A, Brogden RN, Heel RC, Speight TM, Avery GS (1983) Drugs 26: 9–43
Wilkoff LJ, Peckham JC, Dulmadge EA, Mowny RW, Chopra DP (1976) Cancer Res 36: 964–972
Madison K, Tong PS, Marcelo CL, Voorhees JJ (1981) Ro 10-9359 retinoid inhibits both in vitro epidermal cell proliferation and differentation. In: Orfanos et al. (Eds.) Retinoids: Advances in basic research and therapy, Springer, Berlin Heidelberg New York, S. 161
Pohl J, Christophers E (1981) Mitogenic properties of aromatic retinoids: in vivo and in vitro effects on epidermal cells. In; Orfanos et al. (Eds.) Retinoids: Advances in basic research and therapy, Springer, Berlin Heidelberg New York, S. 133–138
Gillenberg H, Immel C, Orfanos CE (1980) Arch Dermatol Res 269: 331–335
Ashton RE, Connor MJ, Lowe NJ (1984) J Invest Dermatol 82: 632–635
Hashimoto T, Dykes PJ, Marks R (1985) Brit J Dermatol 112: 637–646
Stadler R (1989) Three generations of retinoids: basic pharmacological data, mode of action and effect of keratinocyte proliferation and differentiation. In: Greaves MW, Shuster S (Eds.) Pharmacology of the sink II. Heffter-Heubner Hdbch Exp Pharmacol 87/II, Springer, Berlin Heidelberg New York, S. 329–358
Ong DE, Chytil F (1976) Proc Natl Acad Sci 73: 3976–3978
Ong DE, Chytil F (1978) J Biol Chem 253: 4551–4554
Liau G, Ong DE, Chytil F (1981) J Cell Biol 91: 63–68
Gloor M (1982) Pharmakologie dermatologischer Externa, Springer, Berlin Heidelberg New York
Hänni R (1978) Dermatologia 157: 5–10
Ray S, Begg E, Wade D (1981) Clin Exp Pharm Physiol 8: 674
Vahlquist A, Michaelssan G, Kober A, Sjoholm I, Palmskog G, Petersson U (1981) Retinoid-binding proteins and the plasma transport of etretinate (Ro 10-9359) in man. In: Orfanos et al. (Eds.) Retinoids: Advances in basic research and therapy, Springer, Berlin Heidelberg New York, S. 193–199
Paravcini U (1981) Pharmacokinetics and metabolism of oral aromatic retinoids. In: Orfanos et al. (Eds.) Retinoids: Advances in basic research and therapy, Springer, Berlin Heidelberg New York, S. 13–20
Rollmann O, Vahlquist A (1983) Brit J Dermatol 109: 439–447
Paravcini U, Busslinger A (1984) Etretinate and isotretinoin, two retinoids with different pharmacokinetic profiles. In: Miller A, Cunliffe WJ (Eds.) Retinoid therapy, MTP Press, Lancaster, S. 11
Paravcini U, Stockel K, MacNamara PJ, Hänni R, Busslinger A (1981) Ann NY Acad Sci 359: 54–67
Hänni R, Bigler G, Vetter W, Englert G, Loeliger P (1977) Helv Chim Acta 60: 2309–2325
Amblard P, Beani JC, Reymond JL (1981) Lyon Médical 246: 307–308
Grupper C, Beretti B (1981) Dermatologica 162: 404–413
Rhee HJ van der, Polano MK (1981) Treatment of psoriasis vulgaris with low dosage Ro 10-9359 (Tigason) orally combined with corticosteroids topically. In: Orfanos et al. (Eds.) Retinoids: Advances in basic research and therapy, Springer, Berlin Heidelberg New York, S. 193–199
Rhee HJ van der, Tijssen JGP, Herrmann WA, Waterman AH, Polano MK (1980) Brit J Dermatol 102: 203–212
Groot AC de, Nater JP (1988) Dermatological drugs and cosmetics. In: Dukes MNG (Ed.) Meyler’s side effects of drugs, Elsevier, Amsterdam, S. 284–287
Lyons F, Laker MF, Mardsen JR, Manuel R, Shuster S (1982) Brit J Dermatol 107: 591–595
Ellis CN, Swanson NA, Grekin R, Goldstein NG, Bassett DR, Anderson TF, Voorhees JJ (1982) Arch Dermatol 118: 559–562
Groot AC de, Nater JP (1986) Dermatological drugs and cosmetics. In: Dukes MNG (Ed.) Side effects of drugs. Annual 10, Elsevier, Amsterdam, S. 122–124
Happle R, Niedworok A (1981) Cytogenetic studies in patients treated with Ro 10-9359. In: Orfanos et al. (Eds.) Retinoids: Advances in basic research and therapy, Springer, Berlin Heidelberg New York, S. 61–65
Peck GL (1985) Therapy and prevention of skin cancer. In: Saurat (Ed.) Retinoids, Karger, Basel, S. 345–354
Pastori, Valimamod V (1965) Bull Trav Soc Pharm Lyon 9:312, zit. nach CA (1966) 65: 16791h
Clarke EGC (Hrsg.) (1978) Isolation and Identification of Drugs, Bd. 2, The Pharmaceutical Press, London, S. 1039
Soliman SA, Abdine H, Zakhari NA (1975) J Pharm Sci 64: 129–132
Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin
Shroff NE, Pearce MY, Stratford ME, Wilkinson PD (1987) Contraception 35: 121–134
Lauritzen C, Lehmann WD (1969) Besonderheiten der Wirkungen einzelner Gestagene auf Morphologie und Funktion des Genitaltraktes. In: Junkmann K (Hrsg.) Die Gestagene, Kap. IX, Handbuch der experimentellen Pharmakologie, Bd. XXII/2, Springer, Berlin Heidelberg New York, S. 13
Neumann F (1968) Chemische Konstitution und pharmakologische Wirkung. In: Junkmann K (Hrsg.) Die Gestagene, Kap. VI, Handbuch der experimentellen Pharmakologie, Bd. XXII/1, Springer, Berlin Heidelberg New York, S. 964
Orme MLE, Back DJ, Breckenridge AM (1983) Clin Pharmacokin 8: 95–136
Besch PK, Barby RD, Vorys N, Stevens V, Ullery JC (1965) Metabolism 14: 432–443
Drill VA (1965) Metabolism 14: 295–310
Dorflinger LJ (1985) Contraception 31: 557–570
Müller A (1951) Die physiologischen und pharmakologischen Wirkungen der ätherischen Öle, Riechstoffe und verwandten Produkte, Hüthig Verlag, Heidelberg, S. 61
Thomas PA, Bhat KS, Kotian KM, Manipal SK (1980) Oral Surg Oral Med Oral Pathol 49: 166–170
Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Handbuch der Antiseptik, Bd.II/3, Antibakterielle, antifungielle und antivirale Antiseptik — ausgewählte Wirkstoffe, Volk und Gesundheit, Berlin, S. 270–272, 285
Rothenstein AS, Boomann KA, Dorski J (1983) Food Chem Toxicol 21: 727–733
Sekizawa J, Shibamoto T (1982) Mut Res 101: 127–140
Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller JA (1983) Cancer Res 43:1. 124–1. 134
Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Handbuch der Antiseptik, Bd.II/3, Antibakterielle, antifungielle und antivirale Antiseptik — ausgewählte Wirkstoffe, Volk und Gesundheit, Berlin, S. 318
Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 33–35
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
von Bruchhausen, F. et al. (1993). Econazol. In: von Bruchhausen, F., et al. Hagers Handbuch der Pharmazeutischen Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57994-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-57994-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63428-4
Online ISBN: 978-3-642-57994-3
eBook Packages: Springer Book Archive